Scientific articles

• Kalincik et al, incl. Torkildsen Ø, Bo L, Lehmann AK. Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis. JAMA Neurol. 2023 Jul 1;80(7):702-713. doi: 10.1001/ jamaneurol.2023.1184. PMID: 3743740
• Skoie IM, Skogås JG, Langø T, Myhr KM, Myhre PL, Goll R, Fretland SØ, Helland Å. New centres to carry out more clinical trials in Norway. Tidsskr Nor Laegeforen. 2023 Jan 20;143(2). doi: 10.4045/ tidsskr.22.0722. Print 2023 Jan 31. PMID: 36718905 English, Norwegian.
• Førde JL, Herfindal L, Myhr KM, Torkildsen Ø, Mollnes TE, Skrede S. Ocrelizumab and ofatumumab, but not rituximab, trigger complement induction in vitro. Int Immunopharmacol. 2023 Nov;124(Pt B):111021. doi: 10.1016/j.intimp.2023.111021. Epub 2023 Oct 9. PMID: 37816262
• Rød BE, Wergeland S, Bjørnevik K, Holmøy T, Ulvestad E, Njølstad G, Myhr KM, Torkildsen Ø. Humoral response to Epstein-Barr virus in patients with multiple sclerosis treated with B cell depletion therapy. Mult Scler Relat Disord. 2023 Nov;79:105037. doi: 10.1016/j.msard.2023.105037. Epub 2023 Sep 30. PMID: 37804765 Clinical Trial.
• Roar M, Nielsen ARH, Berg JM, Sirakov G, Stilund M, Schäfer J, Ratzer R, Frederiksen J, Asgari N, Ashna SN, Jensen HB, Kant M, Theódorsdóttir Á, Illes Z, Sellebjerg F, Magyari M, Schlosser LM, Nordborg H, Wergeland S, Sejbaek T. Discontinuation of dimethyl fumarate in multiple sclerosis - a nationwide study. Mult Scler Relat Disord. 2023 Dec;80:105127. doi: 10.1016/j.msard.2023.105127. Epub 2023 Nov 5. PMID: 37956521
• Karlowicz JR, Klakegg M, Aarseth JH, Bø L, Myhr KM, Torgauten HM, Torkildsen Ø, Wergeland S. Predictors of hospitalization due to infection in rituximab-treated MS patients. Mult Scler Relat Disord. 2023 Mar;71:104556. doi: 10.1016/j. msard.2023.104556. Epub 2023 Feb 11. PMID: 36842313
• Riemer F, Skorve E, Pasternak O, Zaccagna F, Lundervold AJ, Torkildsen Ø, Myhr KM, Grüner R. Microstructural changes precede depression in patients with relapsing-remitting Multiple Sclerosis. Commun Med (Lond). 2023 Jun 22;3(1):90. doi: 10.1038/s43856-023-00319-4. PMID: 37349545
• Kapali A, Daltveit AK, Myhr KM, Bjornevik K, Baldin E, Pugliatti M, Riise T, Cortese M. Childbirth delivery mode and the risk of multiple sclerosis: a prospective population-based study. J Neurol Neurosurg Psychiatry. 2023 Dec 14;95(1):8-13. doi: 10.1136/jnnp-2023-331241. PMID: 37479464
• Ahmad I, Wergeland S, Oveland E, Bø L. An Association of Chitinase-3 Like-Protein-1 With Neuronal Deterioration in Multiple Sclerosis. ASN Neuro. 2023 Jan-Dec;15:17590914231198980. doi: 10.1177/17590914231198980. PMID: 38062768
• Skorve E, Lundervold AJ, Torkildsen Ø, Riemer F, Grüner R, Myhr KM. Brief international cognitive assessment for MS (BICAMS) and global brain volumes in early stages of MS - A longitudinal correlation study. Mult Scler Relat Disord. 2023 Jan;69:104398. doi: 10.1016/j.msard.2022.104398. Epub 2022 Nov 5. PMID: 36462469
• Grytten N, Myhr KM, Celius EG, Benjaminsen E, Midgard R, Vatne A, Aarseth JH, Mannseth J, Torkildsen Ø. Cancer related mortality in multiple sclerosis. A population based cohort study. Mult Scler Relat Disord. 2023 Jan;69:104417. doi: 10.1016/j. msard.2022.104417. Epub 2022 Nov 17. PMID: 36423459
• Pedullà L, Santoyo-Medina C, Novotna K, Moumdjian L, Smedal T, Arntzen EC, van der Linden ML, Learmonth Y, Kalron A, Güngör F, Nedeljkovic U, Kos D, Jonsdottir J, Coote S, Tacchino A. J. Physical Activity in Multiple Sclerosis: Meeting the Guidelines at the Time of the COVID-19 Pandemic. Neurol Phys Ther. 2023 Apr 1;47(2):112-121. doi: 10.1097/ NPT.0000000000000430. Epub 2023 Jan 31. PMID: 36753458
• Skripuletz T, Torkildsen Ø. Editorial: New cerebrospinal fluid research to uncover mechanisms driving neurological and psychiatric diseases, volume II. Front Neurol. 2023 Dec 12;14:1346377. doi: 10.3389/ fneur.2023.1346377. eCollection 2023. PMID: 38148983 Free PMC article.
• Lie IA, Rød BE, Kvistad SS, Holmøy T, Myhr KM, Torkildsen Ø, Wergeland S. Interferon β1a treatment does not influence serum Epstein-Barr virus antibodies in patients with multiple sclerosis. Mult Scler Relat Disord. 2023 Feb;70:104530. doi: 10.1016/j.msard.2023.104530. Epub 2023 Jan 21. PMID: 36701908
• Kråkenes T, Wergeland S, Al-Sharabi N, MohamedAhmed S, Fromreide S, Costea DE, Mustafa K, Bø L, Kvistad CE. The neuroprotective potential of mesenchymal stem cells from bone marrow and human exfoliated deciduous teeth in a murine model of demyelination. PLoS One. 2023 Nov 9;18(11):e0293908. doi: 10.1371/journal.pone.0293908. eCollection 2023. PMID: 37943848 Free PMC article. Clinical Trial.
• Habbestad A, Willumsen JS, Aarseth JH, Grytten N, Midgard R, Wergeland S, Myhr KM, Torkildsen Ø. Increasing age of multiple sclerosis onset from 1920 to 2022: a population-based study J Neurol. 2023 Dec 14. doi: 10.1007/s00415-023-12047-9. Online ahead of print.PMID: 38097800
• Butzkueven H, Hillert J, Soilu-Hänninen M, Ziemssen T, Kuhle J, Wergeland S, Magyari M, Berger JR, Moore N, Aydemir A, Bezemer I, Sabidó M. The CLARION study: first report on safety findings in patients newly initiating treatment with cladribine tablets or fingolimod for multiple sclerosis. Curr Med Res Opin. 2023 Oct;39(10):1367-1374. doi: 10.1080/03007995.2023.2256220. Epub 2023 Sep 7. PMID: 37675878
• van der Linden ML, Kos D, Moumdjian L, Kalron A, Coote S, Smedal T, Arntzen EC, Tayfur SN, Pedullà L, Tacchino A, Jonsdottir J, Santoyo-Medina C, Novotna K, Yazgan YZ, Nedeljkovic U, Learmonth YC. Changes in physical activity participation during the COVID-19 pandemic in people with multiple sclerosis: An international survey study. Ann Phys Rehabil Med. 2023 Oct;66(7):101798. doi: 10.1016/j.rehab.2023.101798. Epub 2023 Nov 14. PMID: 37967488
• König M, Lorentzen ÅR, Torgauten HM, Tran TT, Schikora-Rustad S, Vaage EB, Mygland Å, Wergeland S, Aarseth J, Aaberge IAS, Torkildsen Ø, Holmøy T, Berge T, Myhr KM, Harbo HF, Andersen JT, Munthe LA, Søraas A, Celius EG, Vaage JT, Lund-Johansen F, Nygaard GO. Humoral immunity to SARS-CoV-2 mRNA vaccination in multiple sclerosis: the relevance of time since last rituximab infusion and first experience from sporadic revaccinations. J Neurol Neurosurg Psychiatry. 2023 Jan;94(1):19- 22. doi: 10.1136/jnnp-2021-327612. Epub 2021 Oct 20. PMID: 34670844 Free PMC article.
• Jonsdottir J, Santoyo-Medina C, Kahraman T, Kalron A, Rasova K, Moumdjian L, Coote S, Tacchino A, Grange E, Smedal T, Arntzen EC, Learmonth Y, Pedulla L, Quinn G, Kos D. Changes in physiotherapy services and use of technology for people with multiple sclerosis during the COVID-19 pandemic. Mult Scler Relat Disord. 2023 Mar;71:104520. doi: 10.1016/j.msard.2023.104520. Epub 2023 Jan 25. PMID: 36724646
• Bhan A, Jacobsen, C, Dalen I, Alves G, Bergsland N, Myhr KM, Zetterberg H, Zivadinov R, Farbu E. Neurofilament and Brain Atrophy and Their Association with Cognition in Multiple Sclerosis: A 10-Year Follow-Up Study. Acta Neurol Scand 2023 DEC 23: DOI10.1155/2023/7136599

1. Skorve E, Lundervold AJ, Torkildsen Ø, Riemer F, Grüner R, Myhr KM. Brief international cognitive assessment for MS (BICAMS) and global brain volumes in early stages of MS - A longitudinal correlation study. Mult Scler Relat Disord. 2023 Jan;69:104398. doi: 10.1016/j.msard.2022.104398. Epub 2022 Nov 5. PMID: 36462469.
2. Grytten N, Myhr KM, Celius EG, Benjaminsen E, Midgard R, Vatne A, Aarseth JH, Mannseth J, Torkildsen Ø. Cancer related mortality in multiple sclerosis. A population based cohort study. Mult Scler Relat Disord. 2023 Jan;69:104417. doi: 10.1016/j.msard.2022.104417. Epub 2022 Nov 17. PMID: 36423459.
3. Eid K, Torkildsen Ø, Aarseth J, Celius EG, Cortese M, Holmøy T, Kapali A, Myhr KM, Torkildsen CF, Wergeland S, Gilhus NE, Bjørk MH. Abuse and revictimization in adulthood in multiple sclerosis: a cross-sectional study during pregnancy. J Neurol. 2022 Nov;269(11):5901-5909. doi: 10.1007/s00415- 022-11249-x. Epub 2022 Jul 3. PMID: 35780399.
4. Torkildsen Ø, Rød BE, Bø L, Wergeland S, Holmøy T, Myhr KM. Breastfeeding and treatment for multiple sclerosis. Tidsskr Nor Laegeforen. 2022 Oct 24;142(15). doi: 10.4045/tidsskr.22.0529. Print 2022 Oct 25. PMID: 36286559.
5. Nakken O, Holmøy T, Stigum H, Myhr KM, Dahl J, Heldal E, Meyer HE. Strong tuberculin response after BCG vaccination is associated with low multiple sclerosis risk: a population-based cohort study. Int J Epidemiol. 2022 Oct 13;51(5):1637-1644. doi: 10.1093/ije/dyac039. PMID: 35278068
6. Willumsen JS, Grytten N, Aarseth J, Myklebust TÅ, Myhr KM, Midgard R. Mortality and cause of death in multiple sclerosis in western Norway 1950-2021: a registry-based linkage study. J Neurol Neurosurg Psychiatry. 2022 Sep 12;93(11):1154-61. doi: 10.1136/jnnp-2022-329169. Online ahead of print. PMID: 36096665.
7. Lie IA, Wesnes K, Kvistad SS, Brouwer I, Wergeland S, Holmøy T, Midgard R, Bru A, Edland A, Eikeland R, Gosal S, Harbo HF, Kleveland G, Sørenes YS, Øksendal N, Barkhof F, Vrenken H, Myhr KM, Bø L, Torkildsen Ø. The Effect of Smoking on Longterm Gray Matter Atrophy and Clinical Disability in Patients with Relapsing-Remitting Multiple Sclerosis. Neurol Neuroimmunol Neuroinflamm. 2022 Jun 23;9(5):e200008. doi: 10.1212/ NXI.0000000000200008. Print 2022 Sep. PMID: 35738901.
8. Hallin EI, Trætteberg Serkland T, Myhr KM, Grytten Torkildsen Ø, Skrede S. Ocrelizumab quantitation by liquid chromatography-tandem mass spectrometry. J Mass Spectrom Adv Clin Lab. 2022 Jul 22;25:53- 60. doi: 10.1016/j.jmsacl.2022.07.004. eCollection 2022 Aug. PMID: 35910410.
9. Kvistad SAS, Burman J, Lehmann AK, Tolf A, Zjukovskaja C, Melve GK, Bø L, Torkildsen Ø. Impact of previous disease-modifying treatment on safety and efficacy in patients with MS treated with AHSCT. J Neurol Neurosurg Psychiatry. 2022 Aug;93(8):844- 848. doi: 10.1136/jnnp-2022-328797. Epub 2022 May 4. PMID: 35508373.
10. Rød BE, Torkildsen Ø, Myhr KM, Bø L, Wergeland S. Safety of breast feeding during rituximab treatment in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2022 Jul 25;94(1):38-41. doi: 10.1136/jnnp-2022- 329545. Online ahead of print. PMID: 35879056.
11. Hestvik ALK, Frederiksen JL, Nielsen HH, Torkildsen Ø, Eek C, Huang-Link Y, Haghighi S, Tsai JA, Kant M. Real-world study of relapsing-remitting multiple sclerosis patients treated with Teriflunomide in Nordic countries: Quality-Of-Life, efficacy, safety and adherence outcomes. Mult Scler Relat Disord. 2022 Jul;63:103892. doi: 10.1016/j.msard.2022.103892. Epub 2022 May 16. PMID: 35696880.
12. Nygaard GO, Torgauten H, Skattebøl L, Høgestøl EA, Sowa P, Myhr KM, Torkildsen Ø, Celius EG. Risk of fingolimod rebound after switching to cladribine or rituximab in multiple sclerosis. Mult Scler Relat Disord. 2022 Jun;62:103812. doi: 10.1016/j. msard.2022.103812. Epub 2022 Apr 17. PMID: 35462167.
13. Eid K, Torkildsen Ø, Aarseth J, Aalstad M, Bhan A, Celius EG, Cortese M, Daltveit AK, Holmøy T, Myhr KM, Riise T, Schüler S, Torkildsen CF, Wergeland S, Gilhus NE, Bjørk MH. Association of adverse childhood experiences with the development of multiple sclerosis. J Neurol Neurosurg Psychiatry. 2022 Jun;93(6):645-650. doi: 10.1136/jnnp-2021- 328700. Epub 2022 Apr 4. PMID: 35379699.
14. Kvistad CE, Kråkenes T, Gjerde C, Mustafa K, Rekand T, Bø L. Safety and Clinical Efficacy of Mesenchymal Stem Cell Treatment in Traumatic Spinal Cord Injury, Multiple Sclerosis and Ischemic Stroke - A Systematic Review and Meta-Analysis. Front Neurol. 2022 May 30;13:891514. doi: 10.3389/ fneur.2022.891514. eCollection 2022. PMID: 35711260.
15. Lie IA, Weeda MM, Mattiesing RM, Mol MAE, Pouwels PJW, Barkhof F, Torkildsen Ø, Bø L, Myhr KM, Vrenken H. Relationship Between White Matter Lesions and Gray Matter Atrophy in Multiple Sclerosis: A Systematic Review. Neurology. 2022 Apr 12;98(15):e1562-e1573. doi: 10.1212/ WNL.0000000000200006. Epub 2022 Feb 16. PMID: 35173016.
16. König M, Torgauten HM, Tran TT, Holmøy T, Vaage JT, Lund-Johansen F, Nygaard GO. Immunogenicity and Safety of a Third SARS-CoV-2 Vaccine Dose in Patients With Multiple Sclerosis and Weak Immune Response After COVID-19 Vaccination. JAMA Neurol. 2022 Mar 1;79(3):307-309. doi: 10.1001/ jamaneurol.2021.5109. PMID: 35072702.
17. Bjornevik K, Cortese M, Healy BC, Kuhle J, Mina MJ, Leng Y, Elledge SJ, Niebuhr DW, Scher AI, Munger KL, Ascherio A. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science. 2022 Jan 21;375(6578):296-301. doi: 10.1126/science. abj8222. Epub 2022 Jan 13. PMID: 35025605.
18. Cortese M, Bjornevik K, Chitnis T, Ascherio A, Munger KL. Aging with multiple sclerosis: A longitudinal study of physical function, mental health, and memory in two cohorts of US women. Mult Scler. 2022 Jan;28(1):121-131. doi: 10.1177/13524585211007739. Epub 2021 Apr 16.PMID: 33860717.

König M, Lorentzen ÅR, Torgauten HM, Tran TT, Schikora-Rustad S, Vaage EB, Mygland Å, Wergeland S, Aarseth J, Aaberge IAS, Torkildsen Ø, Holmøy T, Berge T, Myhr KM, Harbo HF, Andersen JT, Munthe LA, Søraas A, Celius EG, Vaage JT, Lund-Johansen F, Nygaard GO
Humoral immunity to SARS-CoV-2 mRNA vaccination in multiple sclerosis: the relevance of time since last rituximab infusion and first experience from sporadic revaccinations.
J Neurol Neurosurg Psychiatry 2021 Oct 20. Epub 2021 okt 20, PMID: 34670844

Benjaminsen E, Myhr KM, Grytten N, Alstadhaug KB
Comorbidity in multiple sclerosis patients from Nordland County, Norway - validated data from the Norwegian Patient Registry.
Mult Scler Relat Disord 2021 Feb;48():102691. Epub 2020 des 21, PMID: 33360174

Høglund RAA, Meyer HE, Stigum H, Torkildsen Ø, Grytten N, Holmøy T, Nakken O
Association of Body Mass Index in Adolescence and Young Adulthood and Long-term Risk of Multiple Sclerosis: A Population-Based Study.
Neurology 2021 12 07;97(23):e2253-e2261. Epub 2021 okt 25, PMID: 34697245

Wergeland S, Parkar AP, Maric S, Torkildsen Ø
A young woman with persistent nausea, vomiting and hiccups.
Tidsskr Nor Laegeforen 2021 10 12;141(2021-14). Epub 2021 okt 11, PMID: 34641651

Torgauten HM, Myhr KM, Wergeland S, Bø L, Aarseth JH, Torkildsen Ø
Safety and efficacy of rituximab as first- and second line treatment in multiple sclerosis - A cohort study.
Mult Scler J Exp Transl Clin 2021 Jan-Mar;7(1):2055217320973049. Epub 2021 jan 31, PMID: 33796328

Torkildsen Ø
Serum markers of multiple sclerosis - a new approach.
EBioMedicine 2021 Feb;64():103229. Epub 2021 jan 28, PMID: 33516064

Torkildsen Ø, Linker RA, Sesmero JM, Fantaccini S, Sanchez-de la Rosa R, Seze J, Duddy M, Chan A
Living with secondary progressive multiple sclerosis in Europe: perspectives of multiple stakeholders.
Neurodegener Dis Manag 2021 02;11(1):9-19. Epub 2020 nov 25, PMID: 33234006

Bhan A, Jacobsen C, Dalen I, Bergsland N, Zivadinov R, Alves G, Myhr KM, Farbu E
CSF neurofilament light chain predicts 10-year clinical and radiologic worsening in multiple sclerosis.
Mult Scler J Exp Transl Clin 2021 Oct;7(4):20552173211060337. Epub 2021 des 6, PMID: 34900328

Bringeland GH, Blaser N, Myhr KM, Vedeler CA, Gavasso S
Wearing-off symptoms during standard and extended natalizumab dosing intervals: Experiences from the COVID-19 pandemic.
J Neurol Sci 2021 10 15;429():117622. Epub 2021 aug 22, PMID: 34474301

Oveland E, Ahmad I, Lereim RR, Kroksveen AC, Barsnes H, Guldbrandsen A, Myhr KM, Bø L, Berven FS, Wergeland S
Cuprizone and EAE mouse frontal cortex proteomics revealed proteins altered in multiple sclerosis.
Sci Rep 2021 03 30;11(1):7174. Epub 2021 mar 30, PMID: 33785790

Jacobsen C, Zivadinov R, Myhr KM, Dalaker TO, Dalen I, Benedict RH, Bergsland N, Farbu E
Brain atrophy and clinical characteristics predicting SDMT performance in multiple sclerosis: A 10-year follow-up study.
Mult Scler J Exp Transl Clin 2021 Jan-Mar;7(1):2055217321992394. Epub 2021 feb 8, PMID: 33623706

Mosleth EF, Vedeler CA, Liland KH, McLeod A, Bringeland GH, Kroondijk L, Berven FS, Lysenko A, Rawlings CJ, Eid KE, Opsahl JA, Gjertsen BT, Myhr KM, Gavasso S
Cerebrospinal fluid proteome shows disrupted neuronal development in multiple sclerosis.
Sci Rep 2021 02 18;11(1):4087. Epub 2021 feb 18, PMID: 33602999

Holmøy T, Høglund RA, Illes Z, Myhr KM, Torkildsen Ø
Recent progress in maintenance treatment of neuromyelitis optica spectrum disorder.
J Neurol 2021 Dec;268(12):4522-4536. Epub 2020 okt 3, PMID: 33011853

Kønig M, Torgauten HM, Øverås MH, Chopra A, Lorentzen ÅR, Tran T, Mjaaland S, Aaberge IS, Myhr KM, Berge T, Harbo HF, Torkildsen Ø, Holmøy T, Celius EG, Munthe LA, Vaage JT, Lund-Johansen F, Nygaard GO
Efficacy and safety of a third SARS-CoV-2 vaccination in multiple sclerosis vaccine non-responders
https://www.medrxiv.org/content/10.1101/2021.10.15.21264977v1.

Lie IA, Kerklingh E, Wesnes K, van Nederpelt DR, Brouwer I, Torkildsen Ø, Myhr KM, Barkhof F, Bø L, Vrenken H.
The effect of gadolinium-based contrast-agents on automated brain atrophy measurements by FreeSurfer in patients with multiple sclerosis.
Eur Radiol. 2022 Jan 3. doi: 10.1007/s00330-021-08405-8. Epub ahead of print. PMID: 34978580

Holmøy T, Nygaard GO, Myhr KM, Bø L.
Disease-modifying therapy for multiple sclerosis.
Tidsskr Nor Laegeforen. 2021 May 10;141(8). English, Norwegian. doi: 10.4045/tidsskr.21.0155. PMID: 34047171.

Ahmad I, Wergeland S, Oveland E, Bø L.
A higher proportion of ermin-immunopositive oligodendrocytes in areas of remyelination.
PLoS One. 2021 Aug 26;16(8):e0256155. doi: 10.1371/journal.pone.0256155. PMID: 34437581; PMCID: PMC8389439.

Grytten N, Myhr KM, Celius EG, Benjaminsen E, Kampman MT, Midgard R, Vatne A, Aarseth JH, Riise T, Torkildsen Ø.
Incidence of cancer in multiple sclerosis before and after the treatment era- a registry- based cohort study.
Mult Scler Relat Disord. 2021 Aug 9;55:103209. doi: 10.1016/j.msard.2021.103209. Epub ahead of print. PMID: 34419754.

Norborg H, Riise T, Myhr KM, Grytten N, Wergeland S.
Real-world discontinuation rate of teriflunomide and dimethyl fumarate in multiple sclerosis.
Mult Scler J Exp Transl Clin. 2021 Jun 14;7(2):20552173211022027. doi: 10.1177/20552173211022027. PMID: 34188949; PMCID: PMC8209840.

Eid K, Torkildsen ØF, Aarseth J, Flemmen HØ, Holmøy T, Lorentzen ÅR, Myhr KM, Riise T, Simonsen C, Torkildsen CF, Wergeland S, Willumsen JS, Øksendal N, Gilhus NE, Bjørk MH.
Perinatal Depression and Anxiety in Women with Multiple Sclerosis: A Population-Based Cohort Study.
Neurology. 2021 Apr 21:10.1212/WNL.0000000000012062. doi: 10.1212/WNL.0000000000012062. Epub ahead of print. PMID: 33883236.

Wesnes K, Myhr KM, Riise T, et al.
Low vitamin D, but not tobacco use or high BMI, is associated with long-term disability progression in multiple sclerosis. 
Mult Scler Relat Disord. 2021;50:102801. doi:10.1016/j.msard.2021.102801

Skorve E, Lundervold AJ, Torkildsen Ø, Myhr KM
A two-year longitudinal follow-up of cognitive performance assessed by BICAMS in newly diagnosed patients with MS. Mult Scler Relat Disord 2020 Nov;46():102577. Epub 2020 okt 12 PMID:33296975

Kvalvik SA, Skarstein I, Veddeng A, Løland von Volkmann H, Kvalvik T, Torkildsen ØFG, Ebbing C. 
An immunocompromised woman in her twenties with abdominal pain and vaginal discharge. Tidsskr Nor Laegeforen 2020 Nov 10;140(16). Epub 2020 nov 9 PMID:33172234

Torkildsen Ø, Myhr KM, Skogen V, Steffensen LH, Bjørnevik K
Tenofovir as a treatment option for multiple sclerosis. Mult Scler Relat Disord 2020 Nov;46():102569. Epub 2020 okt 7 PMID: 33049462

Holmøy T, Høglund RA, Illes Z, Myhr KM, Torkildsen Ø
Recent progress in maintenance treatment of neuromyelitis optica spectrum disorder. J Neurol 2020 Oct 03. Epub 2020 okt 3 PMID: 33011853

Holmøy T, Torkildsen Ø, Bø L
Treatment of multiple sclerosis under the COVID-19 pandemic. Tidsskr Nor Laegeforen 2020 05 26;140(8). Epub 2020 apr 29 PMID: 32463200

Røsjø E, Lindstrøm JC, Holmøy T, Myhr KM, Varhaug KN, Torkildsen Ø
Natural Variation of Vitamin D and Neurofilament Light Chain in Relapsing-Remitting Multiple Sclerosis. Front Neurol 2020;11():329. Epub 2020 apr 30 PMID: 32425877

Kvistad SAS, Lehmann AK, Trovik LH, Kristoffersen EK, Bø L, Myhr KM, Torkildsen Ø
Safety and efficacy of autologous hematopoietic stem cell transplantation for multiple sclerosis in Norway. Mult Scler 2020 Dec;26(14):1889-1897. Epub 2019 des 13 PMID:31833798

Nystad AE, Lereim RR, Wergeland S, Oveland E, Myhr KM, Bø L, Torkildsen Ø
Fingolimod downregulates brain sphingosine-1-phosphate receptor 1 levels but does not promote remyelination or neuroprotection in the cuprizone model. J Neuroimmunol 2020 02 15;339():577091. Epub 2019 okt 31 PMID: 31739156

Grytten N, Myhr KM, Celius EG, Benjaminsen E, Kampman M, Midgard R, Vatne A, Aarseth JH, Riise T, Torkildsen Ø
Risk of cancer among multiple sclerosis patients, siblings, and population controls: A prospective cohort study. Mult Scler 2020 10;26(12):1569-1580. Epub 2019 okt 1 PMID:31573834

Benjaminsen E, Myhr KM, Grytten N, Alstadhaug KB
Comorbidity in multiple sclerosis patients from Nordland County, Norway - validated data from the Norwegian Patient Registry. Mult Scler Relat Disord 2020 Dec 21;48():102691. Epub 2020 des 21 PMID: 33360174

Bringeland GH, Blaser N, Myhr KM, Vedeler CA, Gavasso S
Wearing-off at the end of natalizumab dosing intervals is associated with low receptor occupancy. Neurol Neuroimmunol Neuroinflamm 2020 05 04;7(3). Epub 2020 feb 4 PMID: 32019768

Bringeland GH, Myhr KM, Vedeler CA, Gavasso S
Wearing-off at the end of natalizumab dosing interval and risk of MS disease activity: A prospective 1-year follow-up study. J Neurol Sci 2020 08 15;415():116880. Epub 2020 mai 5 PMID: 32413799

Kalron A, Ehling R, Baert I, Smedal T, Rasova K, Heric-Mansrud A, Elorriage I, Nedeljkovic U, Tachino A, Gargul L, Gusowski K, Cattaneo D, Borgers S, Hebert J, Dalgas U, Feys P
Improving our understanding of the most important items of the Multiple Sclerosis Walking Scale-12 indicating mobility dysfunction: Secondary results from a RIMS multicenter study. Mult Scler Relat Disord 2020 Nov;46():102511. Epub 2020 sep 14 PMID: 32949848

Rasová K, Freeman J, Cattaneo D, Jonsdottir J, Baert I, Smedal T, Romberg A, Feys P, Alves-Guerreiro J, Habek M, Henze T, Santoyo-Medina C, Beiske A, Asch PV, Bakalidou D, Salci Y, Dimitrova E, Pavlíková M, Štetkárová I, Vorlícková J, Martinková P
Content and Delivery of Physical Therapy in Multiple Sclerosis across Europe: A Survey. Int J Environ Res Public Health 2020 01 31;17(3). Epub 2020 jan 31 PMID: 32023868

Smedal T, Gjelsvik BEB 
What is physiotherapy and where are we heading? Physiother Res Int 2020 01;25(1):e1805. Epub 2019 aug 19 PMID: 31429181

Hakkarainen KM, Juuti R, Burkill S, Geissbühler Y, Sabidó M, Popescu C, Suzart-Woischnik K, Hillert J, Artama M, Verkkoniemi-Ahola A, Myhr KM, Mehtälä J, Bahmanyar S, Montgomery S, Korhonen P 
Pregnancy outcomes after exposure to interferon beta: a register-based cohort study among women with MS in Finland and Sweden. Ther Adv Neurol Disord 2020;13():1756286420951072. Epub 2020 okt 7 PMID: 33101459

Vermersch P, Oh J, Cascione M, Oreja-Guevara C, Gobbi C, Travis LH, Myhr KM, Coyle PK
Teriflunomide vs injectable disease modifying therapies for relapsing forms of MS. Mult Scler Relat Disord 2020 Aug;43():102158. Epub 2020 mai 13 PMID: 32470857

Cortese M, Munger KL, Martínez-Lapiscina EH, Barro C, Edan G, Freedman MS, Hartung HP, Montalbán X, Foley FW, Penner IK, Hemmer B, Fox EJ, Schippling S, Wicklein EM, Kappos L, Kuhle J, Ascherio A,
Vitamin D, smoking, EBV, and long-term cognitive performance in MS: 11-year follow-up of BENEFIT. Neurology 2020 05 05;94(18):e1950-e1960. Epub 2020 apr 16 PMID: 32300060

Butzkueven H, Kappos L, Wiendl H, Trojano M, Spelman T, Chang I, Kasliwal R, Jaitly S, Campbell N, Ho PR, Licata S, 
Long-term safety and effectiveness of natalizumab treatment in clinical practice: 10 years of real-world data from the Tysabri Observational Program (TOP). J Neurol Neurosurg Psychiatry 2020 06;91(6):660-668. Epub 2020 mar 31 PMID: 32234967

Willumsen JS, Aarseth JH, Myhr KM, Midgard R
High incidence and prevalence of MS in Møre and Romsdal County, Norway, 1950-2018. Neurol Neuroimmunol Neuroinflamm 2020 05;7(3). Epub 2020 mar 26 PMID: 32217642

Jacobsen C, Zivadinov R, Myhr KM, Dalaker TO, Dalen I, Bergsland N, Farbu EBrain atrophy and employment in multiple sclerosis patients: a 10-year follow-up study. Mult Scler J Exp Transl Clin 2020 Jan-Mar;6(1):2055217320902481. Epub 2020 jan 27 PMID: 32064116

International Multiple Sclerosis Genetics Consortium.
Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk. Cell 2020 Jan 23;180(2):40 3. PMID: 31978348

Myhr KM, Torkildsen Ø
Serum NFL levels should be used to monitor multiple sclerosis evolution - No. Mult Scler 2020 01;26(1):19-21. Epub 2019 okt 18 PMID: 31625829

Alon Kalron, Rainer Ehling, Ilse Baert, Tori Smedal, Kamila Rasova, Adnan Heric-Mansrud, Iratxe Elorriage, Una Nedeljkovic, Andrea Tachino, Leszek Gargul, Klaus Gusowski, Davide Cattaneo, Sophie Borgers, Jeffrey Hebert, Ulrik Dalgas, Peter Feys
Improving our understanding of the most important items of the Multiple Sclerosis Walking Scale-12 indicating mobility dysfunction: Secondary results from a RIMS multicenter study

Rasova K, Freeman J, Cattaneo D, Jonsdottir J, Baert I, Smedal T, et al.
Content and Delivery of Physical Therapy in Multiple Sclerosis across Europe: A Survey. Int J Environ Res Public Health. 2020;17(3)

Rasova K, Martinkova P, Soler B, Freeman J, Cattaneo D, Jonsdottir J, Smedal T, et al.
Real-World Goal Setting and Use of Outcome Measures According to the International Classification of Functioning, Disability and Health: A European Survey of Physical Therapy Practice in Multiple Sclerosis. Int J Environ Res Public Health. 2020;17(13).

Bringeland GH, Bader L, Blaser N, Budzinski L, Schulz AR, Mei HE, Myhr KM, Vedeler CA, Gavasso S
Optimization of Receptor Occupancy Assays in Mass Cytometry: Standardization Across Channels with QSC Beads. Cytometry A 2019 03;95(3):314-322. Epub 2019 jan 27 PMID: 30688025

Gavasso S, Bringeland GH, Tárnok A
Receptor occupation in the fjords. Cytometry A 2019 Oct;95(10):1044-1045.PMID: 31617331

Burkill S, Vattulainen P, Geissbuehler Y, Sabido Espin M, Popescu C, Suzart-Woischnik K, Hillert J, Artama M, Verkkoniemi-Ahola A, Myhr KM, Cnattingius S, Korhonen P, Montgomery S, Bahmanyar S
The association between exposure to interferon-beta during pregnancy and birth measurements in offspring of women with multiple sclerosis. PLoS One 2019;14(12):e0227120. Epub 2019 des 30 PMID: 31887199

Kvistad SAS, Lehmann AK, Trovik LH, Kristoffersen EK, Bø L, Myhr KM, Torkildsen Ø
Safety and efficacy of autologous hematopoietic stem cell transplantation for multiple sclerosis in Norway. Mult Scler 2019 Dec 13. Epub 2019 des 13 PMID: 31833798

Benjaminsen E, Myhr KM, Grytten N, Alstadhaug KB
Validation of the multiple sclerosis diagnosis in the Norwegian Patient Registry. Brain Behav 2019 Nov;9(11):e01422. Epub 2019 okt 4 PMID: 31583850

Skorve E, Lundervold AJ, Torkildsen Ø, Myhr KM
The Norwegian translation of the brief international cognitive assessment for multiple sclerosis (BICAMS). Mult Scler Relat Disord 2019 Nov;36():101408. Epub 2019 sep 21 PMID: 31610403

Grytten N, Myhr KM, Celius EG, Benjaminsen E, Kampman M, Midgard R, Vatne A, Aarseth JH, Riise T, Torkildsen Ø
Risk of cancer among multiple sclerosis patients, siblings, and population controls: A prospective cohort study. Mult Scler 2019 Oct 01. Epub 2019 okt 1 PMID:31573834

International Multiple Sclerosis Genetics Consortium.
Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk. Cell 2019 Jun 27;178(1):262.  PMID: 31251915

Varhaug KN, Torkildsen Ø, Myhr KM, Vedeler CA
Neurofilament Light Chain as a Biomarker in Multiple Sclerosis.Front Neurol 2019;10():338. Epub 2019 apr 5 PMID: 31024432

Glaser A, Stahmann A, Meissner T, Flachenecker P, Horáková D, Zaratin P, Brichetto G, Pugliatti M, Rienhoff O, Vukusic S, de Giacomoni AC, Battaglia MA, Brola W, Butzkueven H, Casey R, Drulovic J, Eichstädt K, Hellwig K, Iaffaldano P, Ioannidou E, Kuhle J, Lycke K, Magyari M, Malbaša T, Middleton R, Myhr KM, Notas K, Orologas A, Otero-Romero S, Pekmezovic T, Sastre-Garriga J, Seeldrayers P, Soilu-Hänninen M, Stawiarz L, Trojano M, Ziemssen T, Hillert J, Thalheim C
Multiple sclerosis registries in Europe - An updated mapping survey.Mult Scler Relat Disord 2019 01;27():171-178. Epub 2018 okt 4 PMID: 30384204

Myhr KM, Torkildsen Ø, Lossius A, Bø L, Holmøy T
B cell depletion in the treatment of multiple sclerosis. Expert Opin Biol Ther 2019 03;19(3):261-271. Epub 2019 jan 23 PMID: 30632834

Bjornevik K, Myhr KM, Beiske A, Bjerve KS, Holmøy T, Hovdal H, Midgard R, Riise T, Wergeland S, Torkildsen Ø
α-Linolenic acid is associated with MRI activity in a prospective cohort of multiple sclerosis patients. Mult Scler 2019 06;25(7):987-993. Epub 2018 jun 4 PMID:29862891

Magalhaes S, Pugliatti M, Riise T, Myhr KM, Ciampi A, Bjornevik K, Wolfson C
Shedding light on the link between early life sun exposure and risk of multiple sclerosis: results from the EnvIMS Study. Int J Epidemiol 2019 08 01;48(4):1073-1082.  PMID: 30561654

Storm-Larsen C, Myhr KM, Farbu E, Midgard R, Nyquist K, Broch L, Berg-Hansen P, Buness A, Holm K, Ueland T, Fallang LE, Burum-Auensen E, Hov JR, Holmøy T
Gut microbiota composition during a 12-week intervention with delayed-release dimethyl fumarate in multiple sclerosis - a pilot trial.Mult Scler J Exp Transl Clin 2019 Oct-Dec;5(4):2055217319888767. Epub 2019 nov 15 PMID: 31798939

Bergmann Ø, Henriques R, Westin CF, Pasternak O
Fast and accurate initialization of the free-water imaging model parameters from multi-shell diffusion MRI. NMR Biomed 2019 Dec 19. Epub 2019 des 19 PMID: 31856383

Smolders J, Torkildsen Ø, Camu W, Holmøy T
An Update on Vitamin D and Disease Activity in Multiple Sclerosis.CNS Drugs 2019 Dec;33(12):1187-1199. PMID: 31686407

Hobart J, Bowen A, Pepper G, Crofts H, Eberhard L, Berger T, Boyko A, Boz C, Butzkueven H, Celius EG, Drulovic J, Flores J, Horáková D, Lebrun-Frénay C, Marrie RA, Overell J, Piehl F, Rasmussen PV, Sá MJ, Sîrbu CA, Skromne E, Torkildsen Ø, van Pesch V, Vollmer T, Zakaria M, Ziemssen T, Giovannoni G
International consensus on quality standards for brain health-focused care in multiple sclerosis. Mult Scler 2019 Nov;25(13):1809-1818. Epub 2018 nov 1 PMID: 30381987

Hoff JM, Dhayalan M, Midelfart A, Tharaldsen AR, Bø L
Visual dysfunction in multiple sclerosis.Tidsskr Nor Laegeforen 2019 Aug 20;139(11). Epub 2019 aug 2PMID:31429247 Kalron A, Feys P, 

Dalgas U, Smedal T, Freeman J, Romberg A, Conyers H, Elorriaga I, Gebara B, Merilainen J, Heric-Mansrud A, Jensen E, Jones K, Knuts K, Maertens de Noordhout B, Martic A, Normann B, O Eijnde B, Rasova K, Santoyo Medina C, Baert I .
Searching for the "Active Ingredients" in Physical Rehabilitation Programs Across Europe, Necessary to Improve Mobility in People With Multiple Sclerosis: A Multicenter Study. Neurorehabil Neural Repair 2019 04;33(4):260-270. Epub 2019 mar 17 PMID: https://www.ncbi.nlm.nih.gov/pubmed/?term=30880560

Baldin E, Riise T, Mattarozzi K, Gajofatto A, Granella F, Leone M, Lugaresi A, Malagù S, Motti L, Neri W, Pesci I, Santangelo M, Scandellari C, Tola MR, Vignatelli L, Zenesini C, D'Alessandro R. 
Health-related quality of life in clinically isolated syndrome and risk of conversion to multiple sclerosis. Neurol Sci 2019 Jan;40(1):75-80. Epub 2018 sep 25 PMID: 30255488

Antonazzo IC, Poluzzi E, Forcesi E, Riise T, Bjornevik K, Baldin E, Muratori L, De Ponti F, Raschi E
Liver injury with drugs used for multiple sclerosis: A contemporary analysis of the FDA Adverse Event Reporting System. Mult Scler 2019 Oct;25(12):1633-1640. Epub 2018 sep 19 PMID: 30230957

Wesnes K, Bjørnevik K et alVitamin D levels predict long-term disability in multiple sclerosis. European Journal of Neurology, vol 26, S1, EPO 3216

N. Grytten, KM Myhr, EG. Celius, E. Benjaminsen, MT. Kampman, R. Midgard, A. Vatne, JH. Aarseth, T. Riise, ØFG. TorkildsenCancer risk in Multiple sclerosis patients, siblings, and healthy controls: a prospective, longitudinal cohort study. European Journal of Neurology, vol. 26, S1

Baldin, E (Baldin, E.); Daltveit, AK (Daltveit, A. -K.); Riise, T (Riise, T.); Pugliatti, M (Pugliatti, M.). Breastfeeding and risk of developing multiple sclerosis. European Journal of Neurology; Vol 26, SI:

Baldin, E; Zenesini, C; Caniatti, L; Granella, F; Immovilli, P; Lugaresi, A; Malagu, S (Malagu, S.); Montepietra, S; Neri, W; Pasquinelli, M; Pesci,; Poluzzi, E; Pugliatti, M; Riise, T; Salvi, F; Santangelo, M; Sola, P ; Vignatelli, L; D'alessandro, R. Antibiotics use and risk of multiple sclerosis: a case-control study in Emilia-Romagna region, Italy European Jounral of Neurology, Vol 26, SI: 873-874

Magalhaes S, Pugliatti M, Riise T, Myhr KM, Ciampi A, Bjornevik K, Wolfson C.
Shedding light on the link between early life sun exposure and risk of multiple sclerosis: results from the EnvIMS Study.
Int J Epidemiol 2018 Dec 18. Epub 2018 des 18. PMID:30561654

International Multiple Sclerosis Genetics Consortium. 
Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk.
Cell 2018 Nov 29;175(6):1679-1687.e7. Epub 2018 okt 18. PMID:30343897

Kvistad SS, Myhr KM, Holmøy T, Benth Jš, Wergeland S, Beiske AG, Bjerve KS, Hovdal H, Midgard R, Sagen JV, Torkildsen Ø.
Serum levels of leptin and adiponectin are not associated with disease activity or treatment response in multiple sclerosis.
J Neuroimmunol 2018 Oct 15;323():73-77. Epub 2018 jul 24. PMID:30196837

Bhan A, Jacobsen C, Myhr KM, Dalen I, Lode K, Farbu E.
Neurofilaments and 10-year follow-up in multiple sclerosis.
Mult Scler 2018 Sep;24(10):1301-1307. Epub 2018 aug 1. PMID:30066611

Bjornevik K, Myhr KM, Beiske A, Bjerve KS, Holmøy T, Hovdal H, Midgard R, Riise T, Wergeland S, Torkildsen Ø.
α-Linolenic acid is associated with MRI activity in a prospective cohort of multiple sclerosis patients.
Mult Scler 2018 May 01. Epub 2018 mai 1. PMID:29862891

Svendsen B, Grytten N, Bø L, Aarseth H, Smedal T, Myhr KM.
The economic impact of multiple sclerosis to the patients and their families in Norway.
Eur J Health Econ 2018 Dec;19(9):1243-1257. Epub 2018 apr 21. PMID:29680926

Varhaug KN, Barro C, Bjørnevik K, Myhr KM, Torkildsen Ø, Wergeland S, Bindoff LA, Kuhle J, Vedeler C.
Neurofilament light chain predicts disease activity in relapsing-remitting MS.
Neurol Neuroimmunol Neuroinflamm 2018 Jan;5(1):e422. Epub 2017 nov 28. PMID:29209636.

Torkildsen Ø, Holmøy T, Myhr KM.
Severe multiple sclerosis reactivation after gonadotropin treatment.
Mult Scler Relat Disord 2018 May;22():38-40. Epub 2018 mar 6. PMID:29525298

Olberg HK, Eide GE, Cox RJ, Jul-Larsen Å, Lartey SL, Vedeler CA, Myhr KM.
Antibody response to seasonal influenza vaccination in patients with multiple sclerosis receiving immunomodulatory therapy.
Eur J Neurol 2018 03;25(3):527-534. Epub 2018 jan 6. PMID:29205701.

Oveland E, Nystad A, Berven F, Myhr KM, Torkildsen Ø, Wergeland S.
1,25-Dihydroxyvitamin-D3 induces brain proteomic changes in cuprizone mice during remyelination involving calcium proteins.
Neurochem Int 2018 01;112():267-277. Epub 2017 aug 14. PMID:28818673.

Cortese M, Riise T, Bjørnevik K, Myhr KM.
Body size and physical exercise, and the risk of multiple sclerosis.
Mult Scler 2018 Mar;24(3):270-278. Epub 2017 mar 13. PMID:28287051.

Wesnes K, Myhr KM, Riise T, Cortese M, Pugliatti M, Boström I, Landtblom AM, Wolfson C, Bjørnevik K.
Physical activity is associated with a decreased multiple sclerosis risk: The EnvIMS study.
Mult Scler 2018 Feb;24(2):150-157. Epub 2017 feb 1. PMID:28273774.

Hobart J, Bowen A, Pepper G, Crofts H, Eberhard L, Berger T, Boyko A, Boz C, Butzkueven H, Celius EG, Drulovic J, Flores J, Horáková D, Lebrun-Frénay C, Marrie RA, Overell J, Piehl F, Rasmussen PV, Sá MJ, Sîrbu CA, Skromne E, Torkildsen Ø, van Pesch V, Vollmer T, Zakaria M, Ziemssen T, Giovannoni G.
International consensus on quality standards for brain health-focused care in multiple sclerosis.
Mult Scler 2018 Nov 01. Epub 2018 nov 1. PMID:30381987.

Lie IA, Blomberg B, Power ØA, Torkildsen Ø.
A man in his twenties with dizziness, double vision and peripheral facial palsy.
Tidsskr Nor Laegeforen 2018 10 02;138(15). Epub 2018 sep 26. PMID:30277051

Wergeland S, Riise T, Torkildsen Ø.
Response to 'Seasonal variation of vitamin D and Epstein-Barr virus antibody in multiple sclerosis patients', a comment letter regarding 'Vitamin D, HLA-DRB1 and Epstein-Barr virus antibody levels in a prospective cohort of multiple sclerosis patients'.
Eur J Neurol 2018 09;25(9):e104. PMID:30134049.

Holmøy T, Torkildsen Ø, Zarnovicky S.
Extensive Multiple Sclerosis Reactivation after Switching from Fingolimod to Rituximab.
Case Rep Neurol Med 2018;2018():5190794. Epub 2018 jul 19. PMID:30112230.

Nystad AE, Torkildsen Ø, Wergeland S.
Effects of vitamin D on axonal damage during de- and remyelination in the cuprizone model.
J Neuroimmunol 2018 Aug 15;321():61-65. Epub 2018 jun 1. PMID:29957389.

Martinková P, Freeman J, Drabinová A, Erosheva E, Cattaneo D, Jonsdottir J, Baert I, Smedal T, Romberg A, Feys P, Alves-Guerreiro J, Habek M, Henze T, Medina CS, Beiske A, Van Asch P, Bakalidou D, Salci Y, Dimitrova EN, Pavlíková M, Rasová K.
Physiotherapeutic interventions in multiple sclerosis across Europe: Regions and other factors that matter.
Mult Scler Relat Disord 2018 May;22():59-67. Epub 2018 mar 14. PMID:29579644.

Baert I, Smedal T, Kalron A, Rasova K, Heric-Mansrud A, Ehling R, Elorriaga Minguez I, Nedeljkovic U, Tacchino A, Hellinckx P, Adriaenssens G, Stachowiak G, Gusowski K, Cattaneo D, Borgers S, Hebert J, Dalgas U, Feys P.
Responsiveness and meaningful improvement of mobility measures following MS rehabilitation.
Neurology 2018 Nov 13;91(20):e1880-e1892. Epub 2018 okt 17. PMID:30333161.

Cortese M, Riise T, Engeland A, Ascherio A, Bjørnevik K.
Urate and the risk of Parkinson's disease in men and women.
Parkinsonism Relat Disord 2018 Jul;52():76-82. Epub 2018 mar 28. PMID:29615298.

Rotstein DL, Cortese M, Fung TT, Chitnis T, Ascherio A, Munger KL.
Diet quality and risk of multiple sclerosis in two cohorts of US women.
Mult Scler 2018 Oct 23. Epub 2018 okt 23. PMID:30351179.

Wilcox AJ, Cortese M, Baravelli CM, Skjaerven R.
When Intuition Invites the Analytical Mind to Dance-The Essential Role of Creativity in Science.
Epidemiology 2018 11;29(6):753-755. PMID:30074539.

Antonazzo IC, Poluzzi E, Forcesi E, Riise T, Bjornevik K, Baldin E, Muratori L, De Ponti F, Raschi E.
Liver injury with drugs used for multiple sclerosis: A contemporary analysis of the FDA Adverse Event Reporting System.
Mult Scler 2018 Sep 19. Epub 2018 sep 19. PMID:30230957.

Antonazzo IC, Raschi E, Forcesi E, Riise T, Bjornevik K, Baldin E, De Ponti F, Poluzzi E.
Multiple sclerosis as an adverse drug reaction: clues from the FDA Adverse Event Reporting System.
Expert Opin Drug Saf 2018 Sep;17(9):869-874. Epub 2018 aug 11PMID:30058390

Bjornevik K, O'Reilly ÉJ, Berry JD, Clish CB, Jeanfavre S, Kato I, Kolonel LN, Le Marchand L, McCullough ML, Paganoni S, Schwarzschild MA, Talbott EO, Wallace RB, Zhang Z, Manson JE, Ascherio A.
Prediagnostic plasma branched chain amino acids and the risk of amyotrophic lateral sclerosis.
Neurology 2018 Nov 14. Epub 2018 nov 14. PMID:30429276.

Myhr KM.
Tid for en mer offensiv behandlingsstrategi ved multippel sklerose?
BestPractice – Psykiatri/Nevrologi 2018; Årgang 9-Nr.36: 6-7.

Liv Solfrid Bergen, Torild Mauseth, Anne Britt Skår.
Gruppetilbud til ungdom som pårørende ved mulippel sklerose.
Best Practice Psykiatri/nevrologi, nr 35, september 2018, 9.årgang.

Grytten N.
Survival in multiple sclerosis: things have changed.
J Neurol Neurosurg Psychiatry 2017 Aug;88(8):618. PMID: 28705950                            

Lunde HMB, Assmus J, Myhr KM, Bø L, Grytten N.
Survival and cause of death in multiple sclerosis: a 60-year longitudinal population study.
J Neurol Neurosurg Psychiatry 2017 Aug;88(8):621-625. Epub 2017 apr 1 PMID: 28365589                            

Grytten N, Skår AB, Aarseth JH, Assmus J, Farbu E, Lode K, Nyland HI, Smedal T, Myhr KM
The influence of coping styles on long-term employment in multiple sclerosis: A prospective study.
Mult Scler 2017 Jun;23(7):1008-1017. Epub 2016 sep 6 PMID: 27600114                            

Bjørnevik K, Riise T, Benjaminsen E, Celius EG, Dahl OP, Kampman MT, Løken-Amsrud KI, Midgard R, Myhr KM, Torkildsen Ø, Vatne A, Grytten N.
Level of education and multiple sclerosis risk over a 50-year period: Registry-based sibling study.
Mult Scler 2017 Feb;23(2):213-219. Epub 2016 jul 11. PMID: 27207453                            

Holmøy T, Torkildsen Ø, Myhr KM.
An update on cladribine for relapsing-remitting multiple sclerosis.
Expert Opin Pharmacother 2017 Oct;18(15):1627-1635. Epub 2017 sep 11 PMID: 28858531                            

Guldbrandsen A, Farag Y, Kroksveen AC, Oveland E, Lereim RR, Opsahl JA, Myhr KM, Berven FS, Barsnes H.
CSF-PR 2.0: An Interactive Literature Guide to Quantitative Cerebrospinal Fluid Mass Spectrometry Data from Neurodegenerative Disorders.
Mol Cell Proteomics 2017 Feb;16(2):300-309. Epub 2016 nov 27 PMID: 27890865                            

Kroksveen AC, Guldbrandsen A, Vaudel M, Lereim RR, Barsnes H, Myhr KM, Torkildsen Ø, Berven FS.
In-Depth Cerebrospinal Fluid Quantitative Proteome and Deglycoproteome Analysis: Presenting a Comprehensive Picture of Pathways and Processes Affected by Multiple Sclerosis.
J Proteome Res 2017 Jan 06;16(1):179-194. Epub 2016 okt 26 PMID: 27728768                            

Røsjø E, Lossius A, Abdelmagid N, Lindstrøm JC, Kampman MT, Jørgensen L, Sundström P, Olsson T, Steffensen LH, Torkildsen Ø, Holmøy T.
Effect of high-dose vitamin D3 supplementation on antibody responses against Epstein-Barr virus in relapsing-remitting multiple sclerosis.
Mult Scler 2017 Mar;23(3):395-402. Epub 2016 jul 11 PMID: 27325604                            

Olberg HK, Eide GE, Cox RJ, Jul-Larsen Å, Lartey SL, Vedeler CA, Myhr KM.
Antibody response to seasonal influenza vaccination in patients with multiple sclerosis receiving immunomodulatory therapy.
Eur J Neurol 2017 Dec 04. Epub 2017 des 4 PMID: 29205701                            

Myhr KM, Mäurer M, Ginés MM, Esposito F, Linker R.
Break-out session highlights.
Neurodegener Dis Manag 2017 Nov;7(6s):45-49. PMID: 29143586                            

Benjaminsen E, Myhr KM, Alstadhaug KB.
The prevalence and characteristics of epilepsy in patients with multiple sclerosis in Nordland county, Norway.
Seizure 2017 Nov;52():131-135. Epub 2017 okt 6 PMID: 29031194                            

Fitzgerald KC, Munger KL, Hartung HP, Freedman MS, Montalbán X, Edan G, Wicklein EM, Radue EW, Kappos L, Pohl C, Ascherio A.
Sodium intake and multiple sclerosis activity and progression in BENEFIT.
Ann Neurol 2017 Jul;82(1):20-29. PMID: 28556498                            

Cortese M, Riise T, Bjørnevik K, Myhr KM.
Body size and physical exercise, and the risk of multiple sclerosis.
Mult Scler 2017 Mar 01. Epub 2017 mar 1PMID: 28287051                            

Wesnes K, Myhr KM, Riise T, Cortese M, Pugliatti M, Boström I, Landtblom AM, Wolfson C, Bjørnevik K.
Physical activity is associated with a decreased multiple sclerosis risk: The EnvIMS study.
Mult Scler 2017 Feb 01. Epub 2017 feb 1PMID: 28273774                            

Varhaug KN, Vedeler CA, Myhr KM, Aarseth JH, Tzoulis C, Bindoff LA.
Increased levels of cell-free mitochondrial DNA in the cerebrospinal fluid of patients with multiple sclerosis.
Mitochondrion 2017 May;34():32-35. Epub 2016 des 23PMID: 28017684                            

Hauser SL, Bar-Or A, Comi G, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Montalban X, Rammohan KW, Selmaj K, Traboulsee A, Wolinsky JS, Arnold DL, Klingelschmitt G, Masterman D, Fontoura P, Belachew S, Chin P, Mairon N, Garren H, Kappos L.
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.
N Engl J Med 2017 01 19;376(3):221-234. Epub 2016 des 21PMID: 28002679                            

Berger T, Elovaara I, Fredrikson S, McGuigan C, Moiola L, Myhr KM, Oreja-Guevara C, Stoliarov I, Zettl UK.
Alemtuzumab Use in Clinical Practice: Recommendations from European Multiple Sclerosis Experts.
CNS Drugs 2017 Jan;31(1):33-50. PMID: 27882532                            

Bjørnevik K, Riise T, Bostrom I, Casetta I, Cortese M, Granieri E, Holmøy T, Kampman MT, Landtblom AM, Magalhaes S, Pugliatti M, Wolfson C, Myhr KM.
Negative interaction between smoking and EBV in the risk of multiple sclerosis: The EnvIMS study.
Mult Scler 2017 Jun;23(7):1018-1024. Epub 2016 sep 23PMID: 27663872                            

Alstadhaug KB, Myhr KM, Rinaldo CH.
Progressive multifocal leukoencephalopathy.
Tidsskr Nor Laegeforen 2017 12 12;137(23-24). Epub 2017 des 12PMID: 29231623                            

Cortese M, Yuan C, Chitnis T, Ascherio A, Munger KL.
No association between dietary sodium intake and the risk of multiple sclerosis.
Neurology 2017 Sep 26;89(13):1322-1329. Epub 2017 aug 25PMID: 28842447                            

Bjørnevik K, Chitnis T, Ascherio A, Munger KL.
Polyunsaturated fatty acids and the risk of multiple sclerosis.
Mult Scler 2017 Dec;23(14):1830-1838. Epub 2017 feb 3PMID: 28156186                            

Amato MP, Derfuss T, Hemmer B, Liblau R, Montalban X, Soelberg Sørensen P, Miller DH,
Environmental modifiable risk factors for multiple sclerosis: Report from the 2016 ECTRIMS focused workshop.
Mult Scler 2017 01 06. Epub 2017 jan 6PMID: 28671487                            

Antonazzo IC, Raschi E, Vignatelli L, Baldin E, Riise T, D'Alessandro R, De Ponti F, Poluzzi E
Occurrence of Multiple Sclerosis After Drug Exposure: Insights From Evidence Mapping.
Drug Saf 2017 Sep;40(9):823-834. PMID: 28597251                            

Mittal S, Bjørnevik K, Im DS, Flierl A, Dong X, Locascio JJ, Abo KM, Long E, Jin M, Xu B, Xiang YK, Rochet JC, Engeland A, Rizzu P, Heutink P, Bartels T, Selkoe DJ, Caldarone BJ, Glicksman MA, Khurana V, Schüle B, Park DS, Riise T, Scherzer CR
β2-Adrenoreceptor is a regulator of the α-synuclein gene driving risk of Parkinson's disease.
Science 2017 09 01;357(6354):891-898.PMID: 28860381                            

Olafsson S ... Myhr K-M...et al.
Fourteen sequence variants that associate with multiple sclerosis discovered by meta-analysis informed by genetic correlations
NPJ GENOMIC MEDICINE Volume: 2 Article Number: 24 Published AUG 8 2017

Haugstad R
MS-sykepleierfunksjonen i endring.
Bestpractice. Nr 32, November 2017 8. årgang

Grytten Torkildsen N, Myhr K-M
Mestringsstrategien påvirker risikoen for uførhet ved MS.
Bestpractice. Nr. 29, februar 2017, 8. årgang

Guldbrandsen A, Vaudel M, Barsnes H
Fremtiden for biomedisinsk forskning - store endringer gir nye muligheter.
Bestpractice. Nr. 29, februar 2017, 8. årgang

Myhr KM
Tid for taktskifte i sykdomsmodulerende MS- behandling
Bestpractice, Nr. 30, april, 8. årgang

Myhr KM
B- cellemodulering ved behandling av multippel sklerose.
Bestpractice, Nr. 30, april, 8. årgang

Varhaug K, Vedeler CA, Bindoff L
Økt cellefritt mitokondrie-DNA i spinalvæsken til MS pasienter - jakten etter MS- biomarkører.
Bestpractice, Nr. 31, september, årgang 8

Lereim RL, Oveland Eystein, Myhr K-M
Peli1 i immunregulering ved multippel sklerose.
Bestpractice, Nr. 31, september, årgang 8

Cortese M, Riise T, Bjørnevik K, Bhan A, Farbu E, Grytten N, Hogenesch I, Midgard R, Smith Simonsen C, Telstad W, Ascherio A, Myhr KM.
Preclinical disease activity in multiple sclerosis: A prospective study of cognitive performance prior to first symptom.
Ann Neurol. 2016 Oct;80(4):616-24. doi: 10.1002/ana.24769. PubMed PMID: 27554176.

Torkildsen Ø, Myhr KM, Bø L.
Disease-modifying treatments for multiple sclerosis - a review of approved medications.
Eur J Neurol. 2016 Jan;23 Suppl 1:18-27. doi: 10.1111/ene.12883. Review. PubMed PMID: 26563094; PubMed Central PMCID: PMC4670697.

Holmøy T, Esbensen QY, Torkildsen Ø, Wergeland S, Bjerve KS, Beiske AG, Midgard R, Šaltytė-Benth J, Hovdal H, Myhr KM.
WT1 and interferon-β-vitamin D association in MS: a longitudinal study.
Acta Neurol Scand. 2016 Apr;133(4):309-12. doi: 10.1111/ane.12448.  Epub 2015 Jun 2. PubMed PMID:26037530.

Bjørnevik K, Riise T, Cortese M, Holmøy T, Kampman MT, Magalhaes S, Myhr KM, Wolfson C, Pugliatti M.
Level of education and multiple sclerosis risk after adjustment for known risk factors: The EnvIMS study.
Mult Scler. 2016 Jan;22(1):104-11. doi: 10.1177/1352458515579444. Epub 2015 May 26. PubMed PMID: 26014605; PubMed Central PMCID: PMC4702243.

Goulden R, Riise T, Myhr KM, Pugliatti M, Wolfson C.
Does low socioeconomic status in early life protect against multiple sclerosis? A multinational, case-control study.
Eur J Neurol. 2016 Jan;23(1):168-74. doi: 10.1111/ene.12830. Epub 2015 Oct 16. PubMed PMID: 26475404.

Bjørnevik K, Riise T, Bostrom I, Casetta L, Cortese M, Granieri E, Holmøy T, Kampman MT, Landtblom AM, Magalhaes S, Pugliatti M, Wolfson C, Myhr KM.
Negative interaction between smoking and EBV in the risk of multiple sclerosis: The EnvIMS study.
Mult Scler. 2016 Sep 23. pii: 1352458516671028. [Epub ahead of print] PubMed PMID: 27663872.

Kvistad S, Myhr KM, Holmøy T, Benth JŠ, Løken-Amsrud KI, Wergeland S, Beiske AG, Bjerve KS, Hovdal H, Lilleås F, Midgard R, Pedersen T, Bakke SJ, Torkildsen Ø.
No association of tobacco use and disease activity in multiple sclerosis. 
Neurol Neuroimmunol Neuroinflamm. 2016 Jul 14;3(4):e260. doi: 10.1212/NXI.0000000000000260. eCollection 2016 Aug. PubMed PMID: 27458599; PubMed Central PMCID: PMC4946773.

Keshari PK, Harbo HF, Myhr KM, Aarseth JH, Bos SD, Berge T.
Allelic imbalance of multiple sclerosis susceptibility genes IKZF3 and IQGAP1 in human peripheral blood.
BMC Genet. 2016Apr 14;17:59. doi: 10.1186/s12863-016-0367-4. PubMed PMID: 27080863; PubMed Central PMCID: PMC4832550.

Wergeland S, Myhr KM, Løken-Amsrud KI, Beiske AG, Bjerve KS, Hovdal H, Midgard R, Kvistad SS, Holmøy T, Riise T, Torkildsen Ø.
Vitamin D, HLA-DRB1 and Epstein-Barr virus antibody levels in a prospective cohort of multiple sclerosis patients.
Eur J Neurol. 2016 Jun;23(6):1064-70. doi: 10.1111/ene.12986. Epub 2016 Mar 21. PubMed PMID: 26998820.

Opsahl JA, Vaudel M, Guldbrandsen A, Aasebø E, Van Pesch V, Franciotta D, Myhr KM, Barsnes H, Berle M, Torkildsen Ø, Kroksveen AC, Berven FS.
Label-free analysis of human cerebrospinal fluid addressing various normalization strategies and revealing protein groups affected by multiple sclerosis.
Proteomics. 2016 Apr;16(7):1154-65. doi: 10.1002/pmic.201500284. PubMed PMID: 26841090.

Grytten N, Aarseth JH, Lunde HM, Myhr KM.
A 60-year follow-up of the incidence and prevalence of multiple sclerosis in Hordaland County, Western Norway.
J Neurol Neurosurg Psychiatry. 2016 Jan;87(1):100-5. doi: 10.1136/jnnp-2014-309906. Epub 2015 Feb 24. PubMed PMID: 25714916; PubMed Central PMCID: PMC4717445.

Røsjø E, Lossius A, Abdelmagid N, Lindstrøm JC, Kampman MT, Jørgensen L, Sundström P, Olsson T, Steffensen LH, Torkildsen Ø, Holmøy T.
Effect of high-dose vitamin D3 supplementation on antibody responses against Epstein-Barr virus in relapsing-remitting multiple sclerosis.
Mult Scler. 2016 Jun 20. pii: 1352458516654310. [Epub ahead of print] PubMed PMID: 27325604.

Lunde HM, Torkildsen Ø, Bø L, Bertelsen AK.
Botulinum Toxin as Monotherapy in Symptomatic Trigeminal Neuralgia.
Headache. 2016 Jun;56(6):1035-9. doi: 10.1111/head.12791. Epub 2016 Mar 17. PubMed PMID: 26992044.

Torkildsen Ø, Power Ø, Storstein A.
Detection of varicella-zoster virus DNA during medullary and brainstem relapses in multiple sclerosis.
BMJ Case Rep. 2016 Feb 23;2016. pii: bcr2016214555. doi: 10.1136/bcr-2016-214555. PubMed PMID: 26907823.

Holmøy T, Torkildsen Ø.
Can vitamin D reduce inflammation in relapsing-remitting multiple sclerosis?
Expert Rev Neurother. 2016;16(3):233-5. doi: 10.1586/14737175.2016.1146134. Epub 2016 Feb 12. PubMed PMID: 26796244.

Disanto G, Adiutori R, Dobson R, Martinelli V, Dalla Costa G, Runia T, Evdoshenko E, Thouvenot E, Trojano M, Norgren N, Teunissen C, Kappos L, Giovannoni G, Kuhle J; International Clinically Isolated Syndrome Study Group. 
Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome.
J Neurol Neurosurg Psychiatry. 2016 Feb;87(2):126-9. doi: 10.1136/jnnp-2014-309690. Epub 2015 Feb 25. PubMed PMID: 25716934.

Cortese M, Riise T, Bjørnevik K, Holmøy T, Kampman MT, Magalhaes S, Pugliatti M, Wolfson C, Myhr KM. Timing of use of cod liver oil, a vitamin D source, and multiple sclerosis risk: The EnvIMS study. Mult Scler 2015 Dec;21(14):1856-64. Epub 2015 mai 6 PMID:25948625

Grytten N, Torkildsen Ø, Myhr KM. Reply to comments on the review article 'Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades'.. Acta Neurol Scand 2015 Nov;132(5):368-9. Epub 2015 sep 15 PMID:26369381

Grytten N, Torkildsen Ø, Myhr KM. Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades. Acta Neurol Scand 2015;132(199):29-36. PMID:26046556

Myhr KM, Grytten N, Torkildsen Ø, Wergeland S, Bø L, Aarseth JH. The Norwegian Multiple Sclerosis Registry and Biobank. Acta Neurol Scand 2015;132(199):24-8. PMID:26046555

Kroksveen AC, Jaffe JD, Aasebø E, Barsnes H, Bjørlykke Y, Franciotta D, Keshishian H, Myhr KM, Opsahl JA, van Pesch V, Teunissen CE, Torkildsen Ø, Ulvik RJ, Vethe H, Carr SA, Berven FS. Quantitative proteomics suggests decrease in the secretogranin-1 cerebrospinal fluid levels during the disease course of multiple sclerosis.. Proteomics 2015 Oct;15(19):3361-9. Epub 2015 sep 8. PMID:26152395

Kroksveen AC, Opsahl JA, Guldbrandsen A, Myhr KM, Oveland E, Torkildsen Ø, Berven FS. Cerebrospinal fluid proteomics in multiple sclerosis. Biochim Biophys Acta 2015 Jul;1854(7):746-56. Epub 2014 des 16. PMID:25526888

Vaudel M, Verheggen K, Csordas A, Raeder H, Berven FS, Martens L, Vizcaíno JA, Barsnes H. Exploring the potential of public proteomics data.. Proteomics 2015 Oct 9. Epub 2015 okt 9. PMID:26449181

Horvatovich P, Végvári Á, Saul J, Park JG, Qiu J, Syring M, Pirrotte P, Petritis K, Tegeler TJ, Aziz M, Fuentes M, Diez P, Gonzalez-Gonzalez M, Ibarrola N, Droste C, De Las Rivas J, Gil C, Clemente F, Hernaez ML, Corrales FJ, Nilsson CL, Berven FS, Bischoff R, Fehniger TE, LaBaer J, Marko-Varga G. In Vitro Transcription/Translation System: A Versatile Tool in the Search for Missing Proteins. J Proteome Res 2015 Sep 4;14(9):3441-51. Epub 2015 jul 28. PMID:26155874

Wang X, Zhang Y, Nilsson CL, Berven FS, Andrén PE, Carlsohn E, Horvatovich P, Malm J, Fuentes M, Végvári Á, Welinder C, Fehniger TE, Rezeli M, Edula G, Hober S, Nishimura T, Marko-Varga G. Association of chromosome 19 to lung cancer genotypes and phenotypes.. Cancer Metastasis Rev 2015 Jun;34(2):217-26. PMID:25982285

Vaudel M, Burkhart JM, Zahedi RP, Oveland E, Berven FS, Sickmann A, Martens L, Barsnes H. PeptideShaker enables reanalysis of MS-derived proteomics data sets.. Nat Biotechnol 2015 Jan;33(1):22-4. PMID:25574629

Farag Y, Berven FS, Jonassen I, Petersen K, Barsnes H. Distributed and interactive visual analysis of omics data. J Proteomics 2015 Nov 3;129():78-82. Epub 2015 jun 3. PMID:26047716

Oveland E, Muth T, Rapp E, Martens L, Berven FS, Barsnes H. Viewing the proteome: how to visualize proteomics data?. Proteomics 2015 Apr;15(8):1341-55. Epub 2015 jan 21 PMID:25504833

Bjorlykke Y, Vethe H, Vaudel M, Barsnes H, Berven FS, Tjora E, Raeder H. Carboxyl-ester lipase maturity-onset diabetes of the young disease protein biomarkers in secretin-stimulated duodenal juice. J Proteome Res 2015 Jan 2;14(1):521-30. Epub 2014 nov 4

PMID:25369532

Nilsson CL, Mostovenko E, Lichti CF, Ruggles K, Fenyö D, Rosenbloom KR, Hancock WS, Paik YK, Omenn GS, LaBaer J, Kroes RA, Uhlén M, Hober S, Végvári Á, Andrén PE, Sulman EP, Lang FF, Fuentes M, Carlsohn E, Emmett MR, Moskal JR, Berven FS, Fehniger TE, Marko-Varga G. Use of ENCODE resources to characterize novel proteoforms and missing proteins in the human proteome. J Proteome Res 2015 Feb 6;14(2):603-8. Epub 2014 nov 26 PMID:25369122

Kvistad SS, Myhr KM, Holmøy T, Šaltyte Benth J, Wergeland S, Beiske AG, Bjerve KS, Hovdal H, Lilleås F, Midgard R, Pedersen T, Bakke SJ, Michelsen AE, Aukrust P, Ueland T, Sagen JV, Torkildsen Ø. Body mass index influence interferon-beta treatment response in multiple sclerosis. J Neuroimmunol 2015 Nov 15;288():92-7. Epub 2015 sep 26. PMID:26531700

Røsjø E, Steffensen LH, Jørgensen L, Lindstrøm JC, Šaltyte Benth J, Michelsen AE, Aukrust P, Ueland T, Kampman MT, Torkildsen Ø, Holmøy T. Vitamin D supplementation and systemic inflammation in relapsing-remitting multiple sclerosis. J Neurol 2015 Dec;262(12):2713-21. Epub 2015 okt 1 PMID:26429571

Alme MN, Nystad AE, Bø L, Myhr KM, Vedeler CA, Wergeland S, Torkildsen Ø. Fingolimod does not enhance cerebellar remyelination in the cuprizone model.. J Neuroimmunol 2015 Aug 15;285():180-6. Epub 2015 jun 19. PMID:26198937

Holmøy T, Esbensen QY, Torkildsen Ø, Wergeland S, Bjerve KS, Beiske AG, Midgard R, Šaltyte-Benth J, Hovdal H, Myhr KM. WT1 and interferon-ß-vitamin D association in MS: a longitudinal study. Acta Neurol Scand 2015 Jun 2. Epub 2015 jun 2. PMID:26037530

Løken-Amsrud KI, Lossius A, Torkildsen Ø, Holmøy T. Impact of the environment on multiple sclerosis. Tidsskr Nor Laegeforen 2015 May 19;135(9):856-60. Epub 2015 mai 19 PMID:25991624

Røsjø E, Myhr KM, Løken-Amsrud KI, Bakke SJ, Beiske AG, Bjerve KS, Hovdal H, Lilleås F, Midgard R, Pedersen T, Šaltyte Benth J, Torkildsen Ø, Wergeland S, Michelsen AE, Aukrust P, Ueland T, Holmøy T. Vitamin D status and effect of interferon-ß1a treatment on MRI activity and serum inflammation markers in relapsing-remitting multiple sclerosis. J Neuroimmunol 2015 Mar 15;280():21-8. Epub 2015 feb 11 PMID:25773151

Fjær S, Bø L, Myhr KM, Torkildsen Ø, Wergeland S. Magnetization transfer ratio does not correlate to myelin content in the brain in the MOG-EAE mouse model. Neurochem Int 2015 Apr-May;83-84():28-40. Epub 2015 mar 2 PMID:25744931

Kuhle J, Disanto G, Dobson R, Adiutori R, Bianchi L, Topping J, Bestwick JP, Meier UC, Marta M, Dalla Costa G, Runia T, Evdoshenko E, Lazareva N, Thouvenot E, Iaffaldano P, Direnzo V, Khademi M, Piehl F, Comabella M, Sombekke M, Killestein J, Hegen H, Rauch S, D'Alfonso S, Alvarez-Cermeño JC, Kleinová P, Horáková D, Roesler R, Lauda F, Llufriu S, Avsar T, Uygunoglu U, Altintas A, Saip S, Menge T, Rajda C, Bergamaschi R, Moll N, Khalil M, Marignier R, Dujmovic I, Larsson H, Malmestrom C, Scarpini E, Fenoglio C, Wergeland S, Laroni A, Annibali V, Romano S, Martínez AD, Carra A, Salvetti M, Uccelli A, Torkildsen Ø, Myhr KM, Galimberti D, Rejdak K, Lycke J, Frederiksen JL, Drulovic J, Confavreux C, Brassat D, Enzinger C, Fuchs S, Bosca I, Pelletier J, Picard C, Colombo E, Franciotta D, Derfuss T, Lindberg R, Yaldizli Ö, Vécsei L, Kieseier BC, Hartung HP, Villoslada P, Siva A, Saiz A, Tumani H, Havrdová E, Villar LM, Leone M, Barizzone N, Deisenhammer F, Teunissen C, Montalban X, Tintoré M, Olsson T, Trojano M, Lehmann S, Castelnovo G, Lapin S, Hintzen R, Kappos L, Furlan R, Martinelli V, Comi G, Ramagopalan SV, Giovannoni G. Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study. Mult Scler 2015 Jul;21(8):1013-24. Epub 2015 feb 13 PMID:25680984

Fazekas F, Gehring K, Gallo P, Lebrun-Frénay C, Moral E, Myhr KM. Country break-out session highlights. Neurodegener Dis Manag 2015 Dec;5(6 Suppl):31-7. PMID:26611270

Goulden R, Riise T, Myhr KM, Pugliatti M, Wolfson C. Does low socioeconomic status in early life protect against multiple sclerosis? A multinational, case-control study. Eur J Neurol 2015 Oct 16. Epub 2015 okt 16 PMID:26475404

Magalhaes S, Pugliatti M, Casetta I, Drulovic J, Granieri E, Holmøy T, Kampman MT, Landtblom AM, Lauer K, Myhr KM, Parpinel M, Pekmezovic T, Riise T, Wolfson D, Zhu B, Wolfson C. The EnvIMS Study: Design and Methodology of an International Case-Control Study of Environmental Risk Factors in Multiple Sclerosis. Neuroepidemiology 2015;44(3):173-81. Epub 2015 mai 7. PMID:25967369

Ragnedda G, Leoni S, Parpinel M, Casetta I, Riise T, Myhr KM, Wolfson C, Pugliatti M. Reduced duration of breastfeeding is associated with a higher risk of multiple sclerosis in both Italian and Norwegian adult males: the EnvIMS study. J Neurol 2015 May;262(5):1271-7. Epub 2015 mar 21 PMID:25794863

Goris A, Pauwels I, Gustavsen MW, van Son B, Hilven K, Bos SD, Celius EG, Berg-Hansen P, Aarseth J, Myhr KM, D'Alfonso S, Barizzone N, Leone MA, Martinelli Boneschi F, Sorosina M, Liberatore G, Kockum I, Olsson T, Hillert J, Alfredsson L, Bedri SK, Hemmer B, Buck D, Berthele A, Knier B, Biberacher V, van Pesch V, Sindic C, Bang Oturai A, Søndergaard HB, Sellebjerg F, Jensen PE, Comabella M, Montalban X, Pérez-Boza J, Malhotra S, Lechner-Scott J, Broadley S, Slee M, Taylor B, Kermode AG, Gourraud PA, , Sawcer SJ, Andreassen BK, Dubois B, Harbo HF Genetic variants are major determinants of CSF antibody levels in multiple sclerosis. Brain 2015 Mar;138(Pt 3):632-43. Epub 2015 jan 22. PMID:25616667

Sundal C, Baker M, Karrenbauer V, Gustavsen M, Bedri S, Glaser A, Myhr KM, Haugarvoll K, Zetterberg H, Harbo H, Kockum I, Hillert J, Wszolek Z, Rademakers R, Andersen O. Hereditary diffuse leukoencephalopathy with spheroids with phenotype of primary progressive multiple sclerosis. Eur J Neurol 2015 Feb;22(2):328-33. Epub 2014 okt 13 PMID:25311247

Wesnes K, Riise T, Casetta I, Drulovic J, Granieri E, Holmøy T, Kampman MT, Landtblom AM, Lauer K, Lossius A, Magalhaes S, Pekmezovic T, Bjørnevik K, Wolfson C, Pugliatti M, Myhr KM. Body size and the risk of multiple sclerosis in Norway and Italy: the EnvIMS study. Mult Scler 2015 Apr;21(4):388-95. Epub 2014 sep 2 PMID:25182290

Westerlind H, Imrell K, Ramanujam R, Myhr KM, Celius EG, Harbo HF, Oturai AB, Hamsten A, Alfredsson L, Olsson T, Kockum I, Koski T, Hillert J. Identity-by-descent mapping in a Scandinavian multiple sclerosis cohort. Eur J Hum Genet 2015 May;23(5):688-92. Epub 2014 aug 27 PMID:25159868

Rasova K, Martinkova P, Pavlikova M, Cattaneo D, Jonsdottir J, Henze T, Baert I, Van Asch P, Santoyo C, Smedal T, Beiske AG, Stachowiak M, Kovalewski M, Nedeljkovic U, Bakalidou D, Alves-Guerreiro J, Nilsagard Y, Dimitrova EN, Habek M, Armutlu K, Donzé C, Ross E, Ilie AM, Martic A, Freeman J, Romber A, Feys P. Physical therapy provision in multiple sclerosis across Europe: a regional lottery? Eur J Phys Rehabil Med 2015 Sep 2. Epub 2015 sep 2 PMID:26334364

Guldbrandsen Astrid, Vethe Heidrun, Farag Yehia, Oveland Eystein, Garberg Hilde, Berle Magnus, Myhr Kjell-Morten, Opsahl Jill A, Barsnes Harald, Berven Frode S. In-depth characterization of the cerebrospinal fluid (CSF) proteome displayed through the CSF proteome resource (CSF-PR). Mol Cell Proteomics 2014 Nov;13(11):3152-63. Epub 2014 jul 18 PMID: 25038066

Bjørnevik Kjetil, Riise Trond, Casetta Ilaria, Drulovic Jelena, Granieri Enrico, Holmøy Trygve, Kampman Margitta T, Landtblom Anne-Marie, Lauer Klaus, Lossius Andreas, Magalhaes Sandra, Myhr Kjell-Morten, Pekmezovic Tatjana, Wesnes Kristin, Wolfson Christina, Pugliatti Maura. Sun exposure and multiple sclerosis risk in Norway and Italy: The EnvIMS study. Mult Scler 2014 Jan 10;20(8):1042-1049. Epub 2014 jan 10 PMID: 24414538

Wesnes Kristin, Riise Trond, Casetta Ilaria, Drulovic Jelena, Granieri Enrico, Holmøy Trygve, Kampman Margitta T, Landtblom Anne-Marie, Lauer Klaus, Lossius Andreas, Magalhaes Sandra, Pekmezovic Tatjana, Bjørnevik Kjetil, Wolfson Christina, Pugliatti Maura, Myhr Kjell-Morten. Body size and the risk of multiple sclerosis in Norway and Italy: The EnvIMS study. Mult Scler 2014 Sep 2. Epub 2014 sep. PMID: 25182290

Bøe Lunde Hanne Marie, Telstad Wenche, Grytten Nina, Kyte Lars, Aarseth Jan, Myhr Kjell-Morten, Bø Lars. Employment among patients with multiple sclerosis-a population study. PLoS One 2014;9(7):e103317. Epub 2014 jul 23. PMID: 25054972

Torkildsen Oivind, Aarseth Jan, Celius Elisabeth Gulowsen, Holmøy Trygve, Kampman Margitta T, Løken-Amsrud Kristin Ingeleiv, Midgard Rune, Myhr Kjell-Morten, Riise Trond, Grytten Nina. Reply to comment: Month of birth and risk of multiple sclerosis: confounding and adjustments. Ann Clin Transl Neurol 2014 May;1(5):376-7. Epub 2014 apr 10 PMID: 25356407

Torkildsen Oivind, Aarseth Jan, Benjaminsen Espen, Celius Elisabeth, Holmøy Trygve, Kampman Margitta T, Løken-Amsrud Kristin, Midgard Rune, Myhr Kjell-Morten, Riise Trond, Grytten Nina. Month of birth and risk of multiple sclerosis: confounding and adjustments. Ann Clin Transl Neurol 2014 Feb;1(2):141-4. Epub 2014 feb 4 PMID: 25356394

Skår Anne Britt Rundhovde, Folkestad Helge, Smedal Tori, Grytten Nina. "I refer to them as my colleagues": the experience of mutual recognition of self, identity and empowerment in multiple sclerosis. Disabil Rehabil 2014;36(8):672-7. Epub 2013 jul 26 PMID: 23889526

Gavasso Sonia, Mosleth Ellen Faergestad, Marøy Tove, Jørgensen Katarina, Nakkestad Hanne-Linda, Gjertsen Bjørn-Tore, Myhr Kjell-Morten, Vedeler Christian. Deficient phosphorylation of Stat1 in leukocytes identifies neutralizing antibodies in multiple sclerosis patients treated with interferon-beta. PLoS One 2014;9(2):e88632. Epub 2014 feb 19 PMID: 24586361

Baert Ilse, Freeman Jennifer, Smedal Tori, Dalgas Ulrik, Romberg Anders, Kalron Alon, Conyers Helen, Elorriaga Iratxe, Gebara Benoit, Gumse Johanna, Heric Adnan, Jensen Ellen, Jones Kari, Knuts Kathy, Maertens de Noordhout Benoît, Martic Andrej, Normann Britt, Eijnde Bert O, Rasova Kamila, Santoyo Medina Carmen, Truyens Veronik, Wens Inez, Feys Peter. Responsiveness and clinically meaningful improvement, according to disability level, of five walking measures after rehabilitation in multiple sclerosis: a European multicenter study. Neurorehabil Neural Repair 2014 Sep;28(7):621-31. Epub 2014 feb 6 PMID: 24503204

Torkildsen Oivind, Myhr Kjell-Morten, Wergeland Stig. Treatment-resistant immune thrombocytopenic purpura associated with LDN use in a patient with MS. Neurol Neuroimmunol Neuroinflamm 2014 Oct;1(3):e25. Epub 2014 aug 21 PMID: 25340078

Holmøy Trygve, Myhr Kjell-Morten, Bø Lars. Tidsskr Nor Laegeforen 2014 Dec;134(23-24):2239-40. Epub 2014 des 9 PMID: 25492327

Holmøy Trygve, Løken-Amsrud Kristin, Kampman Margitta T, Torkildsen Øivind, Myhr Kjell-Morten. [Re: Vitamin D--how much is enough, and is more better for your health?]. Tidsskr Nor Laegeforen 2014 May 27;134(10):1024-5. Epub 2014 mai 27. PMID: 24865723

Kvistad Silje, Myhr Kjell-Morten, Holmøy Trygve, Bakke Søren, Beiske Antonie G, Bjerve Kristian S, Hovdal Harald, Løken-Amsrud Kristin I, Lilleås Finn, Midgard Rune, Njølstad Gro, Pedersen Tom, Benth Jurate Šaltyte, Wergeland Stig, Torkildsen Oivind. Antibodies to Epstein-Barr virus and MRI disease activity in multiple sclerosis. Mult Scler 2014 Dec;20(14):1833-40. Epub 2014 mai 19 PMID: 24842958

Røsjø Egil, Myhr Kjell-Morten, Løken-Amsrud Kristin Ingeleiv, Bakke Søren Jacob, Beiske Antonie G, Bjerve Kristian S, Hovdal Harald, Lilleås Finn, Midgard Rune, Pedersen Tom, Benth Jurate Saltyte, Torkildsen Øivind, Wergeland Stig, Michelsen Annika E, Aukrust Pål, Ueland Thor, Holmøy Trygve. Increasing serum levels of vitamin A, D and E are associated with alterations of different inflammation markers in patients with multiple sclerosis. J Neuroimmunol 2014 Jun 15;271(1-2):60-5. Epub 2014 mar 24 PMID: 24713402

Lossius Andreas, Riise Trond, Pugliatti Maura, Bjørnevik Kjetil, Casetta Ilaria, Drulovic Jelena, Granieri Enrico, Kampman Margitta T, Landtblom Anne-Marie, Lauer Klaus, Magalhaes Sandra, Myhr Kjell-Morten, Pekmezovic Tatjana, Wesnes Kristin, Wolfson Christina, Holmøy Trygve. Season of infectious mononucleosis and risk of multiple sclerosis at different latitudes; the EnvIMS Study. Mult Scler 2014 May;20(6):669-74. Epub 2013 sep 26 PMID:24072723

Kroksveen Ann C, Opsahl Jill A, Guldbrandsen Astrid, Myhr Kjell-Morten, Oveland Eystein, Torkildsen Øivind, Berven Frode S. Cerebrospinal fluid proteomics in multiple sclerosis. Biochim Biophys Acta 2014 Dec 16. Epub 2014 des 16. PMID: 25526888

Westerlind Helga, Imrell Kerstin, Ramanujam Ryan, Myhr Kjell-Morten, Celius Elisabeth Gulowsen, Harbo Hanne F, Oturai Annette Bang, Hamsten Anders, Alfredsson Lars, Olsson Tomas, Kockum Ingrid, Koski Timo, Hillert Jan Identity-by-descent mapping in a Scandinavian multiple sclerosis cohort. Eur J Hum Genet 2014 Aug 27. Epub 2014 aug 27 PMID: 25159868

Gnanapavan Sharmilee, Hegen Harald, Khalil Michael, Hemmer Bernhard, Franciotta Diego, Hughes Steve, Hintzen Rogier, Jeromin Andreas, Havrdova Eva, Tumani Hayrettin, Bertolotto Antonio, Comabella Manuel, Frederiksen Jette, Álvarez-Cermeño José C, Villar Luisa, Galimberti Daniela, Myhr Kjell-Morten, Dujmovic Irena, Fazekas Franz, Ionete Carolina, Menge Til, Kuhle Jens, Keir Geoffrey, Deisenhammer Florian, Teunissen Charlotte, Giovannoni Gavin. Guidelines for uniform reporting of body fluid biomarker studies in neurologic disorders. Neurology 2014 Sep 23;83(13):1210-6. Epub 2014 aug 22 PMID: 25150289

Gustavsen Marte W, Viken Marte K, Celius Elisabeth G, Berge Tone, Mero Inger-Lise, Berg-Hansen Pål, Aarseth Jan H, Myhr Kjell-Morten, Søndergaard Helle B, Sellebjerg Finn, Oturai Annette B, Hillert Jan, Alfredsson Lars, Olsson Tomas, Kockum Ingrid, Lie Benedicte A, Harbo Hanne F. Oligoclonal band phenotypes in MS differ in their HLA class II association, while specific KIR ligands at HLA class I show association to MS in general. J Neuroimmunol 2014 Sep 15;274(1-2):174-9. Epub 2014 jul 6 PMID: 25037176

Nystad Agnes E, Wergeland Stig, Aksnes Lage, Myhr Kjell-Morten, Bø Lars, Torkildsen Oivind. Effect of high-dose 1.25 dihydroxyvitamin D3 on remyelination in the cuprizone model. APMIS 2014 Dec;122(12):1178-86. Epub 2014 mai 26 PMID: 24862867

Aasebø Elise, Opsahl Jill Anette, Bjørlykke Yngvild, Myhr Kjell-Morten, Kroksveen Ann Cathrine, Berven Frode S. Effects of blood contamination and the rostro-caudal gradient on the human cerebrospinal fluid proteome. PLoS One 2014;9(3):e90429. Epub 2014 mar 5 PMID: 24599184

Jacobsen Cecilie, Hagemeier Jesper, Myhr Kjell-Morten, Nyland Harald, Lode Kirsten, Bergsland Niels, Ramasamy Deepa P, Dalaker Turi O, Larsen Jan Petter, Farbu Elisabeth, Zivadinov Robert. Brain atrophy and disability progression in multiple sclerosis patients: a 10-year follow-up study. J Neurol Neurosurg Psychiatry 2014 Oct;85(10):1109-15. Epub 2014 feb 19 PMID: 24554101

Olberg Henning K, Cox Rebecca J, Nostbakken Jane K, Aarseth Jan H, Vedeler Christian A, Myhr Kjell-Morten. Immunotherapies influence the influenza vaccination response in multiple sclerosis patients: an explorative study. Mult Scler 2014 Jan 16;20(8):1074-1080. Epub 2014 jan 16 PMID: 24436455

Thompson Paul M, Stein Jason L, Medland Sarah E, Hibar Derrek P, Vasquez Alejandro Arias, Renteria Miguel E, Toro Roberto, Jahanshad Neda, Schumann Gunter, Franke Barbara, Wright Margaret J, Martin Nicholas G, Agartz Ingrid, Alda Martin, Alhusaini Saud, Almasy Laura, Almeida Jorge, Alpert Kathryn, Andreasen Nancy C, Andreassen Ole A, Apostolova Liana G, Appel Katja, Armstrong Nicola J, Aribisala Benjamin, Bastin Mark E, Bauer Michael, Bearden Carrie E, Bergmann Orjan, Binder Elisabeth B, Blangero John, Bockholt Henry J, Bøen Erlend, Bois Catherine, Boomsma Dorret I, Booth Tom, Bowman Ian J, Bralten Janita, Brouwer Rachel M, Brunner Han G, Brohawn David G, Buckner Randy L, Buitelaar Jan, Bulayeva Kazima, Bustillo Juan R, Calhoun Vince D, Cannon Dara M, Cantor Rita M, Carless Melanie A, Caseras Xavier, Cavalleri Gianpiero L, Chakravarty M Mallar, Chang Kiki D, Ching Christopher R K, Christoforou Andrea, Cichon Sven, Clark Vincent P, Conrod Patricia, Coppola Giovanni, Crespo-Facorro Benedicto, Curran Joanne E, Czisch Michael, Deary Ian J, de Geus Eco J C, den Braber Anouk, Delvecchio Giuseppe, Depondt Chantal, de Haan Lieuwe, de Zubicaray Greig I, Dima Danai, Dimitrova Rali, Djurovic Srdjan, Dong Hongwei, Donohoe Gary, Duggirala Ravindranath, Dyer Thomas D, Ehrlich Stefan, Ekman Carl Johan, Elvsåshagen Torbjørn, Emsell Louise, Erk Susanne, Espeseth Thomas, Fagerness Jesen, Fears Scott, Fedko Iryna, Fernández Guillén, Fisher Simon E, Foroud Tatiana, Fox Peter T, Francks Clyde, Frangou Sophia, Frey Eva Maria, Frodl Thomas, Frouin Vincent, Garavan Hugh, Giddaluru Sudheer, Glahn David C, Godlewska Beata, Goldstein Rita Z, Gollub Randy L, Grabe Hans J, Grimm Oliver, Gruber Oliver, Guadalupe Tulio, Gur Raquel E, Gur Ruben C, Göring Harald H H, Hagenaars Saskia, Hajek Tomas, Hall Geoffrey B, Hall Jeremy, Hardy John, Hartman Catharina A, Hass Johanna, Hatton Sean N, Haukvik Unn K, Hegenscheid Katrin, Heinz Andreas, Hickie Ian B, Ho Beng-Choon, Hoehn David, Hoekstra Pieter J, Hollinshead Marisa, Holmes Avram J, Homuth Georg, Hoogman Martine, Hong L Elliot, Hosten Norbert, Hottenga Jouke-Jan, Hulshoff Pol Hilleke E, Hwang Kristy S, Jack Clifford R, Jenkinson Mark, Johnston Caroline, Jönsson Erik G, Kahn René S, Kasperaviciute Dalia, Kelly Sinead, Kim Sungeun, Kochunov Peter, Koenders Laura, Krämer Bernd, Kwok John B J, Lagopoulos Jim, Laje Gonzalo, Landen Mikael, Landman Bennett A, Lauriello John, Lawrie Stephen M, Lee Phil H, Le Hellard Stephanie, Lemaître Herve, Leonardo Cassandra D, Li Chiang-Shan, Liberg Benny, Liewald David C, Liu Xinmin, Lopez Lorna M, Loth Eva, Lourdusamy Anbarasu, Luciano Michelle, Macciardi Fabio, Machielsen Marise W J, Macqueen Glenda M, Malt Ulrik F, Mandl René, Manoach Dara S, Martinot Jean-Luc, Matarin Mar, Mather Karen A, Mattheisen Manuel, Mattingsdal Morten, Meyer-Lindenberg Andreas, McDonald Colm, McIntosh Andrew M, McMahon Francis J, McMahon Katie L, Meisenzahl Eva, Melle Ingrid, Milaneschi Yuri, Mohnke Sebastian, Montgomery Grant W, Morris Derek W, Moses Eric K, Mueller Bryon A, Muñoz Maniega Susana, Mühleisen Thomas W, Müller-Myhsok Bertram, Mwangi Benson, Nauck Matthias, Nho Kwangsik, Nichols Thomas E, Nilsson Lars-Göran, Nugent Allison C, Nyberg Lars, Olvera Rene L, Oosterlaan Jaap, Ophoff Roel A, Pandolfo Massimo, Papalampropoulou-Tsiridou Melina, Papmeyer Martina, Paus Tomas, Pausova Zdenka, Pearlson Godfrey D, Penninx Brenda W, Peterson Charles P, Pfennig Andrea, Phillips Mary, Pike G Bruce, Poline Jean-Baptiste, Potkin Steven G, Pütz Benno, Ramasamy Adaikalavan, Rasmussen Jerod, Rietschel Marcella, Rijpkema Mark, Risacher Shannon L, Roffman Joshua L, Roiz-Santiañez Roberto, Romanczuk-Seiferth Nina, Rose Emma J, Royle Natalie A, Rujescu Dan, Ryten Mina, Sachdev Perminder S, Salami Alireza, Satterthwaite Theodore D, Savitz Jonathan, Saykin Andrew J, Scanlon Cathy, Schmaal Lianne, Schnack Hugo G, Schork Andrew J, Schulz S Charles, Schür Remmelt, Seidman Larry, Shen Li, Shoemaker Jody M, Simmons Andrew, Sisodiya Sanjay M, Smith Colin, Smoller Jordan W, Soares Jair C, Sponheim Scott R, Sprooten Emma, Starr John M, Steen Vidar M, Strakowski Stephen, Strike Lachlan, Sussmann Jessika, Sämann Philipp G, Teumer Alexander, Toga Arthur W, Tordesillas-Gutierrez Diana, Trabzuni Daniah, Trost Sarah, Turner Jessica, Van den Heuvel Martijn, van der Wee Nic J, van Eijk Kristel, van Erp Theo G M, Van Haren Neeltje E M, van 't Ent Dennis, van Tol Marie-Jose, Valdés Hernández Maria C, Veltman Dick J, Versace Amelia, Völzke Henry, Walker Robert, Walter Henrik, Wang Lei, Wardlaw Joanna M, Weale Michael E, Weiner Michael W, Wen Wei, Westlye Lars T, Whalley Heather C, Whelan Christopher D, White Tonya, Winkler Anderson M, Wittfeld Katharina, Woldehawariat Girma, Wolf Christiane, Zilles David, Zwiers Marcel P, Thalamuthu Anbupalam, Schofield Peter R, Freimer Nelson B, Lawrence Natalia S, Drevets Wayne, Alzheimer’s Disease Neuroimaging Initiative, EPIGEN Consortium, IMAGEN Consortium, Saguenay Youth Study (SYS) Group. The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data. Brain Imaging Behav 2014 Jun;8(2):153-82. PMID: 24399358

Klevan G, Jacobsen C O, Aarseth J H, Myhr K-M, Nyland H, Glad S, Lode K, Figved N, Larsen J P, Farbu E. Health related quality of life in patients recently diagnosed with multiple sclerosis. Acta Neurol Scand 2014 Jan;129(1):21-6. Epub 2013 jun 15 PMID: 23772958

Flachenecker Peter, Buckow Karoline, Pugliatti Maura, Kes Vanja Bašic, Battaglia Mario A, Boyko Alexey, Confavreux Christian, Ellenberger David, Eskic Danica, Ford David, Friede Tim, Fuge Jan, Glaser Anna, Hillert Jan, Holloway Edward, Ioannidou Eva, Kappos Ludwig, Kasilingam Elisabeth, Koch-Henriksen Nils, Kuhle Jens, Lepore Vito, Middleton Rod, Myhr Kjell-Morton, Orologas Anastasios, Otero Susana, Pitschnau-Michel Dorothea, Rienhoff Otto, Sastre-Garriga Jaume, Schyns-Liharska Tsveta, Sutovic Dragana, Thalheim Christoph, Trojano Maria, Vlasov Yan V, Yaldizli Ozgür, EUReMS Consortium Multiple sclerosis registries in Europe - results of a systematic survey. Mult Scler 2014 Oct;20(11):1523-32. Epub 2014 apr 28 PMID: 24777278

 inne Kenneth, Vethe Heidrun, Skogstrand Trude, Leh Sabine, Dahl Tone D, Tenstad Olav, Berven Frode S, Reed Rolf K, Vikse Bjørn Egil Proteomic analysis of formalin-fixed paraffin-embedded glomeruli suggests depletion of glomerular filtration barrier proteins in two-kidney, one-clip hypertensive rats. Nephrol Dial Transplant 2014 Dec;29(12):2217-27. Epub 2014 aug 16 PMID: 25129444

Helgeland Erik, Breivik Lars Ertesvåg, Vaudel Marc, Svendsen Øyvind Sverre, Garberg Hilde, Nordrehaug Jan Erik, Berven Frode Steingrimsen, Jonassen Anne Kristine. Exploring the human plasma proteome for humoral mediators of remote ischemic preconditioning--a word of caution. PLoS One 2014;9(10):e109279. Epub 2014 okt 15 PMID: 25333471

Aasebø Elise, Vaudel Marc, Mjaavatten Olav, Gausdal Gro, Van der Burgh Arthur, Gjertsen Bjørn Tore, Døskeland Stein Ove, Bruserud Oystein, Berven Frode S, Selheim Frode. Performance of super-SILAC based quantitative proteomics for comparison of different acute myeloid leukemia (AML) cell lines. Proteomics 2014 Sep;14(17-18):1971-6. Epub 2014 aug 8 PMID:25044641

Haaland Ingvild, Opsahl Jill A, Berven Frode S, Reikvam Håkon, Fredly Hanne K, Haugse Ragnhild, Thiede Bernd, McCormack Emmet, Lain Sonia, Bruserud Oystein, Gjertsen Bjørn Tore Molecular mechanisms of nutlin-3 involve acetylation of p53, histones and heat shock proteins in acute myeloid leukemia. Mol Cancer 2014;13():116. Epub 2014 mai 21 PMID:24885082

Vaudel Marc, Venne A Saskia, Berven Frode S, Zahedi René P, Martens Lennart, Barsnes Harald. Shedding light on black boxes in protein identification. Proteomics 2014 May;14(9):1001-5. Epub 2014 mar 20 PMID: 24678044

Lichti Cheryl F, Liu Huiling, Shavkunov Alexander S, Mostovenko Ekaterina, Sulman Erik P, Ezhilarasan Ravesanker, Wang Qianghu, Kroes Roger A, Moskal Joseph C, Fenyö David, Oksuz Betül Akgöl, Conrad Charles A, Lang Frederick F, Berven Frode S, Végvári Akos, Rezeli Melinda, Marko-Varga György, Hober Sophia, Nilsson Carol L. Integrated chromosome 19 transcriptomic and proteomic data sets derived from glioma cancer stem-cell lines. J Proteome Res 2014 Jan 3;13(1):191-9. Epub 2013 des 3 PMID: 24266786

Barsnes Harald, Vaudel Marc, Martens Lennart JSparklines: Making tabular proteomics data come alive. Proteomics 2014 Nov 25. Epub 2014 nov 25 PMID: 25422159

Bjorlykke Yngvild, Vethe Heidrun, Vaudel Marc, Barsnes Harald, Berven Frode S, Tjora Erling, Raeder Helge Carboxyl-Ester Lipase Maturity-Onset Diabetes of the Young Disease Protein Biomarkers in Secretin-Stimulated Duodenal Juice. J Proteome Res 2014 Nov 4. Epub 2014 nov 4PMID: 25369532

Vaudel Marc, Barsnes Harald, Martens Lennart, Berven Frode S Bioinformatics for proteomics: opportunities at the interface between the scientists, their experiments, and the community. Methods Mol Biol 2014;1156():239-48. PMID:24791993

Beck Florian, Geiger Jörg, Gambaryan Stepan, Veit Johannes, Vaudel Marc, Nollau Peter, Kohlbacher Oliver, Martens Lennart, Walter Ulrich, Sickmann Albert, Zahedi René P Time-resolved characterization of cAMP/PKA-dependent signaling reveals that platelet inhibition is a concerted process involving multiple signaling pathways. Blood 2014 Jan 30;123(5):e1-e10. Epub 2013 des 9 PMID: 24324209

Muth Thilo, Weilnböck Lisa, Rapp Erdmann, Huber Christian G, Martens Lennart, Vaudel Marc, Barsnes Harald DeNovoGUI: an open source graphical user interface for de novo sequencing of tandem mass spectra. J Proteome Res 2014 Feb 7;13(2):1143-6. Epub 2014 jan 7 PMID:24295440

Vaudel Marc, Sickmann Albert, Martens Lennart. Introduction to opportunities and pitfalls in functional mass spectrometry based proteomics. Biochim Biophys Acta 2014 Jan;1844(1 Pt A):12-20. Epub 2013 jul 9 PMID: 23845992

Oveland Eystein, Muth Thilo, Rapp Erdmann, Martens Lennart, Berven Frode S, Barsnes Harald. Viewing the proteome: How to visualize proteomics data? Proteomics 2014 Dec 11. Epub 2014 des 11 PMID: 25504833

Kelchtermans Pieter, Bittremieux Wout, De Grave Kurt, Degroeve Sven, Ramon Jan, Laukens Kris, Valkenborg Dirk, Barsnes Harald, Martens Lennart Machine learning applications in proteomics research: how the past can boost the future. Proteomics 2014 Mar;14(4-5):353-66. Epub 2014 jan 21 PMID: 24323524

Verheggen Kenneth, Barsnes Harald, Martens Lennart. Distributed computing and data storage in proteomics: many hands make light work, and a stronger memory. Proteomics 2014 Mar;14(4-5):367-77. Epub 2013 nov 27 PMID: 24285552

Kvistad Silje Agnethe Stokke, Wergeland Stig, Torkildsen Øivind, Myhr Kjell-Morten, Vedeler Christian A.
[Neuromyelitis optica].
Tidsskr Nor Laegeforen 2013 Oct;133(19):2057-61. PMID: 24129537

Fjær Sveinung, Bø Lars, Lundervold Arvid, Myhr Kjell-Morten, Pavlin Tina, Torkildsen Oivind, Wergeland Stig.
Deep gray matter demyelination detected by magnetization transfer ratio in the cuprizone model.
PLoS One 2013;8(12):e84162. Epub 2013 des 30. PMID: 24386344

Grytten N, Aarseth J H, Espeset K, Johnsen G B, Wehus R, Lund C, Haugstad R C.
Stoppers and non-starters of disease-modifying treatment in multiple sclerosis.
Acta Neurol Scand 2013 Feb;127(2):133-40. Epub 2012 aug 25. PMID: 22924678

Malm Johan, Fehniger Thomas E, Danmyr Pia, Végvári Akos, Welinder Charlotte, Lindberg Henrik, Appelqvist Roger, Sjödin Karin, Wieslander Elisabet, Laurell Thomas, Hober Sophia, Berven Frode S, Fenyö David, Wang Xiangdong, Andrén Per E, Edula Goutham, Carlsohn Elisabet, Fuentes Manuel, Nilsson Carol L, Dahlbäck Magnus, Rezeli Melinda, Erlinge David, Marko-Varga György.
Developments in biobanking workflow standardization providing sample integrity and stability.
J Proteomics 2013 Dec;95():38-45. Epub 2013 jul 13. PMID: 23856607

Comi Giancarlo, Martinelli Vittorio, Rodegher Mariaemma, Moiola Lucia, Leocani Letizia, Bajenaru Ovidiu, Carra Adriana, Elovaara Irina, Fazekas Franz, Hartung Hans-Peter, Hillert Jan, King John, Komoly Samuel, Lubetzki Catherine, Montalban Xavier, Myhr Kjell-Morten, Preziosa Paolo, Ravnborg Mads, Rieckmann Peter, Rocca Maria A, Wynn Daniel, Young Carolyn, Filippi Massimo.
Effects of early treatment with glatiramer acetate in patients with clinically isolated syndrome.
Mult Scler 2013 Jul;19(8):1074-83. Epub 2012 des 12. PMID: 23234810

Olsson Tomas, Achiron Anat, Alfredsson Lars, Berger Thomas, Brassat David, Chan Andrew, Comi Giancarlo, Eraksoy Mefkure, Hegen Harald, Hillert Jan, Jensen Poul Erik Hyldgaard, Moiola Lucia, Myhr Kjell-Morten, Oturai Annette, Schippling Sven, Siva Aksel, Sorensen Per Soelberg, Trampe Anne-Kathrin, Weber Thomas, Potts James, Plavina Tatiana, Paes Dominic, Subramanyam Meena, Wiendl Heinz, Dib Hussein, Uren Deniz, Hemmer Bernhard, Buck Dorothea.
Anti-JC virus antibody prevalence in a multinational multiple sclerosis cohort.
Mult Scler 2013 Oct;19(11):1533-8. Epub 2013 mar 4. PMID: 23459571

Mero Inger-Lise, Gustavsen Marte W, Sæther Hanne S, Flåm Siri T, Berg-Hansen Pål, Søndergaard Helle B, Jensen Poul Erik H, Berge Tone, Bjølgerud Anja, Muggerud Aslaug, Aarseth Jan H, eUtils.ItemsChoiceType2[], Myhr Kjell-Morten, Celius Elisabeth G, Sellebjerg Finn, Hillert Jan, Alfredsson Lars, Olsson Tomas, Oturai Annette Bang, Kockum Ingrid, Lie Benedicte A, Andreassen Bettina Kulle, Harbo Hanne F.
Oligoclonal band status in Scandinavian multiple sclerosis patients is associated with specific genetic risk alleles.
PLoS One 2013;8(3):e58352. Epub 2013 mar 5. PMID: 23472185

Svenningsson Anders, Falk Eva, Celius Elisabeth G, Fuchs Siegrid, Schreiber Karen, Berkö Sara, Sun Jennifer, Penner Iris-Katharina, eUtils.ItemsChoiceType2[].
Natalizumab treatment reduces fatigue in multiple sclerosis. Results from the TYNERGY trial; a study in the real life setting.
PLoS One 2013;8(3):e58643. Epub 2013 mar 21. PMID: 23555589

Mechelli Rosella, Umeton Renato, Policano Claudia, Annibali Viviana, Coarelli Giulia, Ricigliano Vito A G, Vittori Danila, Fornasiero Arianna, Buscarinu Maria Chiara, eUtils.ItemsChoiceType2[], eUtils.ItemsChoiceType2[], Romano Silvia, Salvetti Marco, Ristori Giovanni.
A "candidate-interactome" aggregate analysis of genome-wide association data in multiple sclerosis.
PLoS One 2013;8(5):e63300. Epub 2013 mai 16. PMID: 23696811

eUtils.ItemsChoiceType2[]
Network-based multiple sclerosis pathway analysis with GWAS data from 15,000 cases and 30,000 controls.
Am J Hum Genet 2013 Jun;92(6):854-65. Epub 2013 mai 23. PMID: 23731539

Klevan G, Jacobsen C O, Aarseth J H, Myhr K-M, Nyland H, Glad S, Lode K, Figved N, Larsen J P, Farbu E.
Health related quality of life in patients recently diagnosed with multiple sclerosis.
Acta Neurol Scand 2014 Jan;129(1):21-6. Epub 2013 jun 15. PMID: 23772958

Leone Maurizio A, Barizzone Nadia, Esposito Federica, Lucenti Ausiliatrice, Harbo Hanne F, Goris An, Kockum Ingrid, Oturai Annette Bang, Celius Elisabeth Gulowsen, Mero Inger L, Dubois Bénédicte, Olsson Tomas, Søndergaard Helle Bach, Cusi Daniele, Lupoli Sara, Andreassen Bettina Kulle, eUtils.ItemsChoiceType2[], eUtils.ItemsChoiceType2[], Myhr Kjell-Morten, Guerini Franca R, eUtils.ItemsChoiceType2[], eUtils.ItemsChoiceType2[], Comi Giancarlo, Martinelli-Boneschi Filippo, D'alfonso Sandra.
Association of genetic markers with CSF oligoclonal bands in multiple sclerosis patients.
PLoS One 2013;8(6):e64408. Epub 2013 jun 13. PMID: 23785401

Holmøy Trygve, Løken-Amsrud Kristin Ingeleiv, Bakke Søren Jacob, Beiske Antonie G, Bjerve Kristian S, Hovdal Harald, Lilleås Finn, Midgard Rune, Pedersen Tom, Saltyte Benth Jutrate, Torkildsen Oivind, Wergeland Stig, Myhr Kjell-Morten, Michelsen Annika E, Aukrust Pål, Ueland Thor.
Inflammation markers in multiple sclerosis: CXCL16 reflects and may also predict disease activity.
PLoS One 2013;8(9):e75021. Epub 2013 sep 19. PMID: 24069377

Lossius Andreas, Riise Trond, Pugliatti Maura, Bjørnevik Kjetil, Casetta Ilaria, Drulovic Jelena, Granieri Enrico, Kampman Margitta T, Landtblom Anne-Marie, Lauer Klaus, Magalhaes Sandra, Myhr Kjell-Morten, Pekmezovic Tatjana, Wesnes Kristin, Wolfson Christina, Holmøy Trygve.
Season of infectious mononucleosis and risk of multiple sclerosis at different latitudes; the EnvIMS Study.
Mult Scler 2013 Sep 26. Epub 2013 sep 26. PMID: 24072723

Beecham Ashley H, Patsopoulos Nikolaos A, Xifara Dionysia K, Davis Mary F, Kemppinen Anu, Cotsapas Chris, Shah Tejas S, Spencer Chris, Booth David, Goris An, Oturai Annette, Saarela Janna, Fontaine Bertrand, Hemmer Bernhard, Martin Claes, Zipp Frauke, D'alfonso Sandra, Martinelli-Boneschi Filippo, Taylor Bruce, Harbo Hanne F, Kockum Ingrid, Hillert Jan, Olsson Tomas, Ban Maria, Oksenberg Jorge R, Hintzen Rogier, Barcellos Lisa F, eUtils.ItemsChoiceType2[], eUtils.ItemsChoiceType2[], Agliardi Cristina, Alfredsson Lars, Alizadeh Mehdi, Anderson Carl, Andrews Robert, Søndergaard Helle Bach, Baker Amie, Band Gavin, Baranzini Sergio E, Barizzone Nadia, Barrett Jeffrey, Bellenguez Céline, Bergamaschi Laura, Bernardinelli Luisa, Berthele Achim, Biberacher Viola, Binder Thomas M C, Blackburn Hannah, Bomfim Izaura L, Brambilla Paola, Broadley Simon, Brochet Bruno, Brundin Lou, Buck Dorothea, Butzkueven Helmut, Caillier Stacy J, Camu William, Carpentier Wassila, Cavalla Paola, Celius Elisabeth G, Coman Irène, Comi Giancarlo, Corrado Lucia, Cosemans Leentje, Cournu-Rebeix Isabelle, Cree Bruce A C, Cusi Daniele, Damotte Vincent, Defer Gilles, Delgado Silvia R, Deloukas Panos, di Sapio Alessia, Dilthey Alexander T, Donnelly Peter, Dubois Bénédicte, Duddy Martin, Edkins Sarah, Elovaara Irina, Esposito Federica, Evangelou Nikos, Fiddes Barnaby, Field Judith, Franke Andre, Freeman Colin, Frohlich Irene Y, Galimberti Daniela, Gieger Christian, Gourraud Pierre-Antoine, Graetz Christiane, Graham Andrew, Grummel Verena, Guaschino Clara, Hadjixenofontos Athena, Hakonarson Hakon, Halfpenny Christopher, Hall Gillian, Hall Per, Hamsten Anders, Harley James, Harrower Timothy, Hawkins Clive, Hellenthal Garrett, Hillier Charles, Hobart Jeremy, Hoshi Muni, Hunt Sarah E, Jagodic Maja, Jelcic Ilijas, Jochim Angela, Kendall Brian, Kermode Allan, Kilpatrick Trevor, Koivisto Keijo, Konidari Ioanna, Korn Thomas, Kronsbein Helena, Langford Cordelia, Larsson Malin, Lathrop Mark, Lebrun-Frenay Christine, Lechner-Scott Jeannette, Lee Michelle H, Leone Maurizio A, Leppä Virpi, Liberatore Giuseppe, Lie Benedicte A, Lill Christina M, Lindén Magdalena, Link Jenny, Luessi Felix, Lycke Jan, Macciardi Fabio, Männistö Satu, Manrique Clara P, Martin Roland, Martinelli Vittorio, Mason Deborah, Mazibrada Gordon, McCabe Cristin, Mero Inger-Lise, Mescheriakova Julia, Moutsianas Loukas, Myhr Kjell-Morten, Nagels Guy, Nicholas Richard, Nilsson Petra, Piehl Fredrik, Pirinen Matti, Price Siân E, Quach Hong, Reunanen Mauri, Robberecht Wim, Robertson Neil P, Rodegher Mariaemma, Rog David, Salvetti Marco, Schnetz-Boutaud Nathalie C, Sellebjerg Finn, Selter Rebecca C, Schaefer Catherine, Shaunak Sandip, Shen Ling, Shields Simon, Siffrin Volker, Slee Mark, Sorensen Per Soelberg, Sorosina Melissa, Sospedra Mireia, Spurkland Anne, Strange Amy, Sundqvist Emilie, Thijs Vincent, Thorpe John, Ticca Anna, Tienari Pentti, van Duijn Cornelia, Visser Elizabeth M, Vucic Steve, Westerlind Helga, Wiley James S, Wilkins Alastair, Wilson James F, Winkelmann Juliane, Zajicek John, Zindler Eva, Haines Jonathan L, Pericak-Vance Margaret A, Ivinson Adrian J, Stewart Graeme, Hafler David, Hauser Stephen L, Compston Alastair, McVean Gil, De Jager Philip, Sawcer Stephen J, McCauley Jacob L.
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis.
Nat Genet 2013 Nov;45(11):1353-60. Epub 2013 sep 29. PMID: 24076602

Salzer Jonatan, Myhr Kjell-Morten.
Epstein-Barr virus is a necessary causative agent in the pathogenesis of multiple sclerosis: No.
Mult Scler 2013 Nov;19(13):1692-3. PMID: 24218487

Lunde H M B, Bjorvatn B, Myhr K-M, Bø L.
Clinical assessment and management of sleep disorders in multiple sclerosis: a literature review.
Acta Neurol Scand Suppl 2013. PMID: 23190288

Bertelsen A K, Tøndel C, Krohn J, Bull N, Aarseth J, Houge G, Mellgren S I, Vedeler C A.
Small fibre neuropathy in Fabry disease.
J Neurol 2013 Mar;260(3):917-9. Epub 2012 des 21. PMID: 23263477

Totland Cecilie, Ying Ming, Haugen Mette, Mazengia Kibret, Storstein Anette, Aarseth Jan, Martinez Aurora, Vedeler Christian.
Avidity of onconeural antibodies is of clinical relevance.
Cancer Immunol Immunother 2013 Aug;62(8):1393-6. Epub 2013 jun 4. PMID: 23733227

Haász Judit, Westlye Erling T, Fjær Sveinung, Espeseth Thomas, Lundervold Arvid, Lundervold Astri J.
General fluid-type intelligence is related to indices of white matter structure in middle-aged and old adults.
Neuroimage 2013 Dec;83():372-83. Epub 2013 jun 19. PMID: 23791837

Torkildsen Ø, Løken-Amsrud K I, Wergeland S, Myhr K-M, Holmøy T.
Fat-soluble vitamins as disease modulators in multiple sclerosis.
Acta Neurol Scand Suppl 2013. PMID: 23190287

Grytten Nina, Torkildsen Øivind, Aarseth Jan Harald, Benjaminsen Espen, Celius Elisabeth Gulowsen, Dahl Ole Petter, Holmøy Trygve, Løken-Amsrud Kristin, Midgard Rune, Myhr Kjell-Morten, Risberg Geir, Vatne Anita, Kampman Margitta T.
Month of birth as a latitude-dependent risk factor for multiple sclerosis in Norway.
Mult Scler 2013 Jul;19(8):1028-34. Epub 2012 des 20. PMID: 23257620

Løken-Amsrud Kristin I, Myhr Kjell-Morten, Bakke Søren J, Beiske Antonie G, Bjerve Kristian S, Bjørnarå Bård T, Hovdal Harald, Lilleås Finn, Midgard Rune, Pedersen Tom, Benth Jurate Saltyte, Torkildsen Øivind, Wergeland Stig, Holmøy Trygve.
Retinol levels are associated with magnetic resonance imaging outcomes in multiple sclerosis.
Mult Scler 2013 Apr;19(4):451-7. Epub 2012 aug 20. PMID: 22907941

Løken-Amsrud Kristin I, Myhr Kjell-Morten, Bakke Søren J, Beiske Antonie G, Bjerve Kristian S, Bjørnarå Bård T, Hovdal Harald, Lilleås Finn, Midgard Rune, Pedersen Tom, Benth Jurate Šaltyte, Torkildsen Øivind, Wergeland Stig, Holmøy Trygve.
Alpha-tocopherol and MRI outcomes in multiple sclerosis--association and prediction.
PLoS One 2013;8(1):e54417. Epub 2013 jan 22. PMID: 23349882

Ban Maria, Caillier Stacy, Mero Inger-Lise, Myhr Kjell-Morten, Celius Elisabeth G, Aarseth Jan, Torkildsen Øivind, Harbo Hanne F, Oksenberg Jorge, Hauser Stephen L, Sawcer Stephen, Compston Alastair.
No evidence of association between mutant alleles of the CYP27B1 gene and multiple sclerosis.
Ann Neurol 2013 Mar;73(3):430-2. Epub 2013 feb 26. PMID: 23444327

Xiao Yichuan, Jin Jin, Chang Mikyoung, Chang Jae-Hoon, Hu Hongbo, Zhou Xiaofei, Brittain George C, Stansberg Christine, Torkildsen Øivind, Wang Xiaodong, Brink Robert, Cheng Xuhong, Sun Shao-Cong.
Peli1 promotes microglia-mediated CNS inflammation by regulating Traf3 degradation.
Nat Med 2013 May;19(5):595-602. Epub 2013 apr 21. PMID: 23603814

Kroksveen Ann C, Aasebø Elise, Vethe Heidrun, Van Pesch Vincent, Franciotta Diego, Teunissen Charlotte E, Ulvik Rune J, Vedeler Christian, Myhr Kjell-Morten, Barsnes Harald, Berven Frode S.
Discovery and initial verification of differentially abundant proteins between multiple sclerosis patients and controls using iTRAQ and SID-SRM.
J Proteomics 2013 Jan 14;78():312-25. Epub 2012 okt 8. PMID: 23059536

Feys Peter, Baert Ilse, Dalgas Ulrik, Smedal Tor.
Need for differentiation of real and clinical important change in research on responsiveness of walking outcome measures in multiple sclerosis.
Mult Scler 2013 Sep. Epub 2013 sep 3. PMID: 23999608

Provan F, Jensen L B, Uleberg K E, Larssen E, Rajalahti T, Mullins J, Obach A.
Proteomic analysis of epidermal mucus from sea lice-infected Atlantic salmon, Salmo salar L.
J Fish Dis 2013 Mar;36(3):311-21. Epub 2013 jan 11. PMID: 23305410

Berle Magnus, Kroksveen Ann Cathrine, Garberg Hilde, Aarhus Mads, Haaland Oystein Ariansen, Wester Knut, Ulvik Rune Johan, Helland Christian, Berven Frode.
Quantitative proteomics comparison of arachnoid cyst fluid and cerebrospinal fluid collected perioperatively from arachnoid cyst patients.
Fluids Barriers CNS 2013;10(1):17. Epub 2013 apr 29. PMID: 23628075

Teunissen Charlotte, Menge Til, Altintas Ayse, Alvarez-Cermeño José C, Bertolotto Antonio, Berven Frode S, Brundin Lou, Comabella Manuel, Degn Matilde, Deisenhammer Florian, Fazekas Franz, Franciotta Diego, Frederiksen Jette L, Galimberti Daniela, Gnanapavan Sharmilee, Hegen Harald, Hemmer Bernhard, Hintzen Rogier, Hughes Steve, Iacobaeus Ellen, Kroksveen Ann C, Kuhle Jens, Richert John, Tumani Hayrettin, Villar Luisa M, Drulovic Jelena, Dujmovic Irena, Khalil Michael, Bartos Ales.
Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis.
Mult Scler 2013 Nov;19(13):1802-9. Epub 2013 mai 21. PMID: 23695446

Kampman Margitta T, Aarseth Jan Harald, Grytten Nina, Benjaminsen Espen, Celius Elisabeth Gulowsen, Dahl Ole Petter, Holmøy Trygve, Løken-Amsrud Kristin, Midgard Rune, Myhr Kjell-Morten, Risberg Geir, Vatne Anita, Torkildsen Oivind.
Sex ratio of multiple sclerosis in persons born from 1930 to 1979 and its relation to latitude in Norway.
J Neurol 2013 Jun;260(6):1481-8. Epub 2013 jan 6. PMID: 23292231

Skår Anne Britt Rundhovde, Folkestad Helge, Smedal Tori, Grytten Nina.
"I refer to them as my colleagues": the experience of mutual recognition of self, identity and empowerment in multiple sclerosis.
Disabil Rehabil 2013 Jul. Epub 2013 jul 26.PMID: 23889526

Torkildsen Oivind, Wergeland Stig, Bakke Søren, Beiske Antonie G, Bjerve Kristian S, Hovdal Harald, Midgard Rune, Lilleås Finn, Pedersen Tom, Bjørnarå Bård, Dalene Frøydis, Kleveland Grethe, Schepel Jan, Olsen Inge Christoffer, Myhr Kjell-Morten
?-3 fatty acid treatment in multiple sclerosis (OFAMS Study): a randomized, double-blind, placebo-controlled trial.
Arch Neurol 2012 Aug;69(8):1044-51.

Saltyte Benth J, Myhr K-M, Løken-Amsrud K I, Beiske A G, Bjerve K S, Hovdal H, Midgard R, Holmøy T
Modelling and prediction of 25-hydroxyvitamin D levels in Norwegian relapsing-remitting multiple sclerosis patients.
Neuroepidemiology 2012;39(2):84-93. Epub 2012 jul 17

Myhr K M, Grytten N, Torkildsen O, Wergeland S, Bø L, Pugliatti M, Aarseth J H
A need for national registries and international collaborative research in multiple sclerosis.
Acta Neurol Scand Suppl 2012.

Svendsen B, Myhr K-M, Nyland H, Aarseth J H
The cost of multiple sclerosis in Norway.
Eur J Health Econ 2012 Feb;13(1):81-91. Epub 2010 nov 16

Myhr K-M, Grytten N, Aarseth J H
The norwegian multiple sclerosis registry and biobank.
Acta Neurol Scand Suppl 2012.

Pugliatti M, Casetta I, Drulovic J, Granieri E, Holmøy T, Kampman M T, Landtblom A-M, Lauer K, Myhr K-M, Parpinel M, Pekmezovic T, Riise T, Zhu B, Wolfson C
A questionnaire for multinational case-control studies of environmental risk factors in multiple sclerosis (EnvIMS-Q).
Acta Neurol Scand Suppl 2012.

Oveland Eystein, Karlsen Tine V, Haslene-Hox Hanne, Semaeva Elvira, Janaczyk Bartlomiej, Tenstad Olav, Wiig Helge
Proteomic evaluation of inflammatory proteins in rat spleen interstitial fluid and lymph during LPS-induced systemic inflammation reveals increased levels of ADAMST1.
J Proteome Res 2012 Nov;11(11):5338-49. Epub 2012 okt 24

Nesvåg Ragnar, Bergmann Ørjan, Rimol Lars M, Lange Elisabeth H, Haukvik Unn K, Hartberg Cecilie B, Fagerberg Thomas, Söderman Erik, Jönsson Erik G, Agartz Ingrid
A 5-year follow-up study of brain cortical and subcortical abnormalities in a schizophrenia cohort.
Schizophr Res 2012 Dec;142(1-3):209-16. Epub 2012 okt 30

Skrede Silje, Fernø Johan, Vázquez María Jesús, Fjær Sveinung, Pavlin Tina, Lunder Niclas, Vidal-Puig Antonio, Diéguez Carlos, Berge Rolf Kristian, López Miguel, Steen Vidar Martin
Olanzapine, but not aripiprazole, weight-independently elevates serum triglycerides and activates lipogenic gene expression in female rats.
Int J Neuropsychopharmacol 2012 Mar;15(2):163-79. Epub 2011 aug 19

Bøe Lunde Hanne Marie, Aae Tommy F, Indrevåg William, Aarseth Jan, Bjorvatn Bjørn, Myhr Kjell-Morten, Bø Lars
Poor sleep in patients with multiple sclerosis.
PLoS One 2012;7(11):e49996. Epub 2012 nov 14

Gjelsvik Bente, Breivik Kyrre, Verheyden Geert, Smedal Tori, Hofstad Håkon, Strand Liv Inger
The Trunk Impairment Scale - modified to ordinal scales in the Norwegian version.
Disabil Rehabil 2012;34(16):1385-95. Epub 2011 des 23

Mjaavatten Olav, Nygaard Gyrid, Berven Frode S, Selheim Frode
Minimization of side reactions during Lys Tag derivatization of C-terminal lysine peptides.
Anal Chim Acta 2012 Jan;712():101-7. Epub 2011 nov 19

Boström Inger, Riise Trond, Landtblom Anne-Marie
Mortality statistics for multiple sclerosis and amyotrophic lateral sclerosis in Sweden.
Neuroepidemiology 2012;38(4):245-9. Epub 2012 jun 5

Bertelsen A K, Tøndel C, Krohn J, Bull N, Aarseth J, Houge G, Mellgren S I, Vedeler C A
Small fibre neuropathy in Fabry disease.
J Neurol 2012 Dec. Epub 2012 des 21

Pugliatti M, Eskic D, Mikolcic T, Pitschnau-Michel D, Myhr K-M, Sastre-Garriga J, Otero S, Wieczynska L, Torje C, Holloway E, Rienhoff O, Friede T, Buckow K, Ellenberger D, Hillert J, Glaser A, Flachenecker P, Fuge J, Schyns-Liharska T, Kasilingam E, Moretti A, Thalheim C, eUtils.ItemsChoiceType2[]
Assess, compare and enhance the status of Persons with Multiple Sclerosis (MS) in Europe: a European Register for MS.
Acta Neurol Scand Suppl 2012.

Aye Thin Thin, Low Teck Yew, Bjørlykke Yngvild, Barsnes Harald, Heck Albert J R, Berven Frode S
Use of stable isotope dimethyl labeling coupled to selected reaction monitoring to enhance throughput by multiplexing relative quantitation of targeted proteins.
Anal Chem 2012 Jun;84(11):4999-5006. Epub 2012 mai 15

Mero Inger-Lise, Smestad Cathrine, Lie Benedicte A, Lorentzen Åslaug R, Sandvik Leiv, Landrø Nils Inge, Aarseth Jan H, Myhr Kjell-Morten, Celius Elisabeth G, Harbo Hanne F
Polymorphisms of the BDNF gene show neither association with multiple sclerosis susceptibility nor clinical course.
J Neuroimmunol 2012 Mar;244(1-2):107-10. Epub 2012 feb 15

Grimaldi L, Barkhof F, Beelke M, Burton J, Holmoy T, Hupperts R, Killestein J, Rieckmann P, Schluep M, Smolders J, eUtils.ItemsChoiceType2[]
A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis.
Neurology 2012 Mar;78(11):841.

Comi Giancarlo, Martinelli Vittorio, Rodegher Mariaemma, Moiola Lucia, Leocani Letizia, Bajenaru Ovidiu, Carra Adriana, Elovaara Irina, Fazekas Franz, Hartung Hans-Peter, Hillert Jan, King John, Komoly Samuel, Lubetzki Catherine, Montalban Xavier, Myhr Kjell-Morten, Preziosa Paolo, Ravnborg Mads, Rieckmann Peter, Rocca Maria A, Wynn Daniel, Young Carolyn, Filippi Massimo
Effects of early treatment with glatiramer acetate in patients with clinically isolated syndrome.
Mult Scler 2012 Dec. Epub 2012 des 12

Gavasso S, Gjertsen BT, Anderssen E, Myhr KM, Vedeler C
Immunogenic effects of recombinant interferon-beta therapy disrupt the JAK/STAT pathway in primary immune cells from patients with multiple sclerosis.
Mult Scler 2012 Aug;18(8):1116-24. Epub 2012 jan 27

Grytten N, Aarseth J H, Espeset K, Berg Johnsen G, Wehus R, Lund C, Riise T, Haugstad R
Health-related quality of life and disease-modifying treatment behaviour in relapsing-remitting multiple sclerosis - a multicentre cohort study.
Acta Neurol Scand Suppl 2012.

Grytten N, Aarseth J H, Espeset K, Johnsen G B, Wehus R, Lund C, Haugstad R C
Stoppers and non-starters of disease-modifying treatment in multiple sclerosis.
Acta Neurol Scand 2012 Aug. Epub 2012 aug 25

Kroksveen A C, Guldbrandsen A, Vedeler C, Myhr K M, Opsahl J A, Berven F S. Cerebrospinal fluid proteome comparison between multiple sclerosis patients and controls.
Acta Neurol Scand Suppl 2012.

Kroksveen Ann C, Aasebø Elise, Vethe Heidrun, Van Pesch Vincent, Franciotta Diego, Teunissen Charlotte E, Ulvik Rune J, Vedeler Christian, Myhr Kjell-Morten, Barsnes Harald, Berven Frode S
Discovery and initial verification of differentially abundant proteins between multiple sclerosis patients and controls using iTRAQ and SID-SRM.
J Proteomics 2012 Oct. Epub 2012 okt 8

Løken-Amsrud Kristin I, Holmøy Trygve, Bakke Søren J, Beiske Antonie Giaever, Bjerve Kristian S, Bjørnarå Bård T, Hovdal Harald, Lilleås Finn, Midgard Rune, Pedersen Tom, Benth Jurate Saltyte, Sandvik Leiv, Torkildsen Oivind, Wergeland Stig, Myhr Kjell-Morten
Vitamin D and disease activity in multiple sclerosis before and during interferon-ß treatment.
Neurology 2012 Jul;79(3):267-73. Epub 2012 jun 13

Wergeland Stig, Torkildsen Øivind, Myhr Kjell-Morten, Mørk Sverre Jarl, Bø Lars
The cuprizone model: regional heterogeneity of pathology.
APMIS 2012 Aug;120(8):648-57. Epub 2012 feb 24

Løken-Amsrud Kristin I, Myhr Kjell-Morten, Bakke Søren J, Beiske Antonie G, Bjerve Kristian S, Bjørnarå Bård T, Hovdal Harald, Lilleås Finn, Midgard Rune, Pedersen Tom, Benth Jurate Saltyte, Torkildsen Oivind, Wergeland Stig, Holmøy Trygve
Retinol levels are associated with magnetic resonance imaging outcomes in multiple sclerosis.
Mult Scler 2012 Aug. Epub 2012 aug 20

Grytten Nina, Torkildsen Oivind, Aarseth Jan Harald, Benjaminsen Espen, Celius Elisabeth Gulowsen, Dahl Ole Petter, Holmøy Trygve, Løken-Amsrud Kristin, Midgard Rune, Myhr Kjell-Morten, Risberg Geir, Vatne Anita, Kampman Margitta T
Month of birth as a latitude-dependent risk factor for multiple sclerosis in Norway.
Mult Scler 2012 Dec. Epub 2012 des 20

Torkildsen O, Grytten N, Aarseth J, Myhr K-M, Kampman M T
Month of birth as a risk factor for multiple sclerosis: an update.
Acta Neurol Scand Suppl 2012.

Holmøy T, Torkildsen O, Myhr K-M, Løken-Amsrud K I
Vitamin D supplementation and monitoring in multiple sclerosis: who, when and wherefore.
Acta Neurol Scand Suppl 2012.

Wergeland S, Torkildsen O, Bø L, Myhr K-M
Polyunsaturated fatty acids in multiple sclerosis therapy.
Acta Neurol Scand Suppl 2012.

Gavasso S, Torkildsen O, Marøy T H, Ulvestad E, Myhr K-M, Vedeler C A
Fc? receptors in Norwegian multiple sclerosis patients and healthy controls.
Acta Neurol Scand Suppl 2012.

Smedal T, Beiske A G, Glad S B, Myhr K-M, Aarseth J H, Svensson E, Gjelsvik B, Strand L I
Fatigue in multiple sclerosis: associations with health-related quality of life and physical performance.
Eur J Neurol 2011 Jan;18(1):114-20.

Riise T, Mohr D C, Munger K L, Rich-Edwards J W, Kawachi I, Ascherio A
Stress and the risk of multiple sclerosis.
Neurology 2011 May;76(22):1866-71.

Risberg Geir, Aarseth Jan Harald, Nyland Harald, Lauer Klaus, Myhr Kjell-Morten, Midgard Rune
Prevalence and incidence of multiple sclerosis in Oppland County: a cross-sectional population-based study in a landlocked county of Eastern Norway.
Acta Neurol Scand 2011 Oct;124(4):250-7. Epub 2010 des 10

Glad Solveig B, Nyland Harald, Aarseth Jan Harald, Riise Trond, Myhr Kjell-Morten
How long can you keep working with benign multiple sclerosis?
J Neurol Neurosurg Psychiatry 2011 Jan;82(1):78-82. Epub 2010 aug 27

Rajalahti Tarja, Kvalheim Olav M
Multivariate data analysis in pharmaceutics: a tutorial review.
Int J Pharm 2011 Sep;417(1-2):280-90. Epub 2011 feb 16

Storstein Anette, Monstad Sissel Evy, Haugen Mette, Mazengia Kibret, Veltman Dana, Lohndal Emilia, Aarseth Jan, Vedeler Christian
Onconeural antibodies: improved detection and clinical correlations.
J Neuroimmunol 2011 Mar;232(1-2):166-70. Epub 2010 nov 19

Mero I-L, Ban M, Lorentzen Å R, Smestad C, Celius E G, Sæther H, Saeedi H, Viken M K, Skinningsrud B, Undlien D E, Aarseth J, Myhr K-M, Granum S, Spurkland A, Sawcer S, Compston A, Lie B A, Harbo H F. Exploring the CLEC16A gene reveals a MS-associated variant with correlation to the relative expression of CLEC16A isoforms in thymus.
Genes Immun 2011 Apr;12(3):191-8. Epub 2010 des 23

Riise Trond, Kirkeleit Jorunn, Aarseth Jan Harald, Farbu Elisabeth, Midgard Rune, Mygland Åse, Eikeland Randi, Mørland Tore Jørgen, Telstad Wenche, Førland Per Tore, Myhr Kjell-Morten
Risk of MS is not associated with exposure to crude oil, but increases with low level of education.
Mult Scler 2011 Jul;17(7):780-7. Epub 2011 feb 22

Sørensen Per Soelberg, Jensen Poul Erik Hyldgaard, Haghikia Aiden, Lundkvist Malin, Vedeler Christian, Sellebjerg Finn, Koch-Henriksen Nils, Fogdell-Hahn Anna, Myhr Kjell-Morten, Hillert Jan, Gold Ralf
Occurrence of antibodies against natalizumab in relapsing multiple sclerosis patients treated with natalizumab.
Mult Scler 2011 Sep;17(9):1074-8. Epub 2011 apr 20

Sorensen Per Soelberg, Lycke Jan, Erälinna Juha-Pekka, Edland Astrid, Wu Xingchen, Frederiksen Jette Lautrup, Oturai Annette, Malmeström Clas, Stenager Egon, Sellebjerg Finn, Sondergaard Helle Bach, PubMed.ItemsChoiceType2[]
Simvastatin as add-on therapy to interferon ß-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study): a placebo-controlled randomised phase 4 trial.
Lancet Neurol 2011 Aug;10(8):691-701.

Sawcer Stephen, Hellenthal Garrett, Pirinen Matti, Spencer Chris C A, Patsopoulos Nikolaos A, Moutsianas Loukas, Dilthey Alexander, Su Zhan, Freeman Colin, Hunt Sarah E, Edkins Sarah, Gray Emma, Booth David R, Potter Simon C, Goris An, Band Gavin, Oturai Annette Bang, Strange Amy, Saarela Janna, Bellenguez Céline, Fontaine Bertrand, Gillman Matthew, Hemmer Bernhard, Gwilliam Rhian, Zipp Frauke, Jayakumar Alagurevathi, Martin Roland, Leslie Stephen, Hawkins Stanley, Giannoulatou Eleni, D'alfonso Sandra, Blackburn Hannah, Boneschi Filippo Martinelli, Liddle Jennifer, Harbo Hanne F, Perez Marc L, Spurkland Anne, Waller Matthew J, Mycko Marcin P, Ricketts Michelle, Comabella Manuel, Hammond Naomi, Kockum Ingrid, McCann Owen T, Ban Maria, Whittaker Pamela, Kemppinen Anu, Weston Paul, Hawkins Clive, Widaa Sara, Zajicek John, Dronov Serge, Robertson Neil, Bumpstead Suzannah J, Barcellos Lisa F, Ravindrarajah Rathi, Abraham Roby, Alfredsson Lars, Ardlie Kristin, Aubin Cristin, Baker Amie, Baker Katharine, Baranzini Sergio E, Bergamaschi Laura, Bergamaschi Roberto, Bernstein Allan, Berthele Achim, Boggild Mike, Bradfield Jonathan P, Brassat David, Broadley Simon A, Buck Dorothea, Butzkueven Helmut, Capra Ruggero, Carroll William M, Cavalla Paola, Celius Elisabeth G, Cepok Sabine, Chiavacci Rosetta, Clerget-Darpoux Françoise, Clysters Katleen, Comi Giancarlo, Cossburn Mark, Cournu-Rebeix Isabelle, Cox Mathew B, Cozen Wendy, Cree Bruce A C, Cross Anne H, Cusi Daniele, Daly Mark J, Davis Emma, de Bakker Paul I W, Debouverie Marc, D'hooghe Marie Beatrice, Dixon Katherine, Dobosi Rita, Dubois Bénédicte, Ellinghaus David, Elovaara Irina, Esposito Federica, Fontenille Claire, Foote Simon, Franke Andre, Galimberti Daniela, Ghezzi Angelo, Glessner Joseph, Gomez Refujia, Gout Olivier, Graham Colin, Grant Struan F A, Guerini Franca Rosa, Hakonarson Hakon, Hall Per, Hamsten Anders, Hartung Hans-Peter, Heard Rob N, Heath Simon, Hobart Jeremy, Hoshi Muna, Infante-Duarte Carmen, Ingram Gillian, Ingram Wendy, Islam Talat, Jagodic Maja, Kabesch Michael, Kermode Allan G, Kilpatrick Trevor J, Kim Cecilia, Klopp Norman, Koivisto Keijo, Larsson Malin, Lathrop Mark, Lechner-Scott Jeannette S, Leone Maurizio A, Leppä Virpi, Liljedahl Ulrika, Bomfim Izaura Lima, Lincoln Robin R, Link Jenny, Liu Jianjun, Lorentzen Aslaug R, Lupoli Sara, Macciardi Fabio, Mack Thomas, Marriott Mark, Martinelli Vittorio, Mason Deborah, McCauley Jacob L, Mentch Frank, Mero Inger-Lise, Mihalova Tania, Montalban Xavier, Mottershead John, Myhr Kjell-Morten, Naldi Paola, Ollier William, Page Alison, Palotie Aarno, Pelletier Jean, Piccio Laura, Pickersgill Trevor, Piehl Fredrik, Pobywajlo Susan, Quach Hong L, Ramsay Patricia P, Reunanen Mauri, Reynolds Richard, Rioux John D, Rodegher Mariaemma, Roesner Sabine, Rubio Justin P, Rückert Ina-Maria, Salvetti Marco, Salvi Erika, Santaniello Adam, Schaefer Catherine A, Schreiber Stefan, Schulze Christian, Scott Rodney J, Sellebjerg Finn, Selmaj Krzysztof W, Sexton David, Shen Ling, Simms-Acuna Brigid, Skidmore Sheila, Sleiman Patrick M A, Smestad Cathrine, Sørensen Per Soelberg, Søndergaard Helle Bach, Stankovich Jim, Strange Richard C, Sulonen Anna-Maija, Sundqvist Emilie, Syvänen Ann-Christine, Taddeo Francesca, Taylor Bruce, Blackwell Jenefer M, Tienari Pentti, Bramon Elvira, Tourbah Ayman, Brown Matthew A, Tronczynska Ewa, Casas Juan P, Tubridy Niall, Corvin Aiden, Vickery Jane, Jankowski Janusz, Villoslada Pablo, Markus Hugh S, Wang Kai, Mathew Christopher G, Wason James, Palmer Colin N A, Wichmann H-Erich, Plomin Robert, Willoughby Ernest, Rautanen Anna, Winkelmann Juliane, Wittig Michael, Trembath Richard C, Yaouanq Jacqueline, Viswanathan Ananth C, Zhang Haitao, Wood Nicholas W, Zuvich Rebecca, Deloukas Panos, Langford Cordelia, Duncanson Audrey, Oksenberg Jorge R, Pericak-Vance Margaret A, Haines Jonathan L, Olsson Tomas, Hillert Jan, Ivinson Adrian J, De Jager Philip L, Peltonen Leena, Stewart Graeme J, Hafler David A, Hauser Stephen L, McVean Gil, Donnelly Peter, Compston Alastair
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis.
Nature 2011 Aug;476(7359):214-9. Epub 2011 aug 10

Hartung H-P, Freedman M S, Polman C H, Edan G, Kappos L, Miller D H, Montalbán X, Barkhof F, Petkau J, White R, Sahajpal V, Knappertz V, Beckmann K, Lanius V, Sandbrink R, Pohl C, PubMed.ItemsChoiceType2[]
Interferon ß-1b-neutralizing antibodies 5 years after clinically isolated syndrome.
Neurology 2011 Aug;77(9):835-43. Epub 2011 aug 17

Skrede Silje, Fernø Johan, Vázquez María Jesús, Fjær Sveinung, Pavlin Tina, Lunder Niclas, Vidal-Puig Antonio, Diéguez Carlos, Berge Rolf Kristian, López Miguel, Steen Vidar Martin
Olanzapine, but not aripiprazole, weight-independently elevates serum triglycerides and activates lipogenic gene expression in female rats.
Int J Neuropsychopharmacol 2011 Aug. Epub 2011 aug 19

Wergeland Stig, Torkildsen Øivind, Myhr Kjell-Morten, Aksnes Lage, Mørk Sverre Jarl, Bø Lars
Dietary vitamin D3 supplements reduce demyelination in the cuprizone model.
PLoS One 2011;6(10):e26262. Epub 2011 okt 20

Smedal T, Myhr K-M, Aarseth J H, Gjelsvik B, Beiske A G, Glad S B, Strand L I
The influence of warm versus cold climate on the effect of physiotherapy in multiple sclerosis.
Acta Neurol Scand 2011 Jul;124(1):45-52. Epub 2010 jul 15

Vaudel Marc, Barsnes Harald, Berven Frode S, Sickmann Albert, Martens Lennart
SearchGUI: An open-source graphical user interface for simultaneous OMSSA and X!Tandem searches.
Proteomics 2011 Mar;11(5):996-9. Epub 2011 jan 31

Barsnes Harald, Vaudel Marc, Colaert Niklaas, Helsens Kenny, Sickmann Albert, Berven Frode S, Martens Lennart
compomics-utilities: an open-source Java library for computational proteomics.
BMC Bioinformatics 2011;12():70. Epub 2011 mar 8

Teunissen Charlotte E, Tumani Hayrettin, Bennett Jeffrey L, Berven Frode S, Brundin Lou, Comabella Manuel, Franciotta Diego, Federiksen Jette L, Fleming John O, Furlan Roberto, Hintzen Rogier Q, Hughes Steve G, Jimenez Connie R, Johnson Michael H, Killestein Joep, Krasulova Eva, Kuhle Jens, Magnone Maria-Chiara, Petzold Axel, Rajda Cecilia, Rejdak Konrad, Schmidt Hollie K, Van Pesch Vincent, Waubant Emmanuelle, Wolf Christian, Deisenhammer Florian, Giovannoni Gavin, Hemmer Bernhard
Consensus Guidelines for CSF and Blood Biobanking for CNS Biomarker Studies.
Mult Scler Int 2011;2011():246412. Epub 2011 jul 18

Berle Magnus, Kroksveen Ann C, Haaland Oystein A, Aye Thin T, Opsahl Jill A, Oveland Eystein, Wester Knut, Ulvik Rune J, Helland Christian A, Berven Frode S
Protein profiling reveals inter-individual protein homogeneity of arachnoid cyst fluid and high qualitative similarity to cerebrospinal fluid.
Fluids Barriers CNS 2011;8():19. Epub 2011 mai 20

Kroksveen A C, Opsahl J A, Aye T T, Ulvik R J, Berven F S. Proteomics of human cerebrospinal fluid: discovery and verification of biomarker candidates in neurodegenerative diseases using quantitative proteomics.
J Proteomics 2011 Apr;74(4):371-88. Epub 2010 nov 25

Svendsen B, Myhr K-M, Nyland H, Aarseth J H. The cost of multiple sclerosis in Norway. Eur J Health Econ 2010 Nov. Epub 2010 nov 16

Risberg Geir, Aarseth Jan Harald, Nyland Harald, Lauer Klaus, Myhr Kjell-Morten, Midgard Rune. Prevalence and incidence of multiple sclerosis in Oppland County - a cross-sectional population-based study in a landlocked county of Eastern Norway. Acta Neurol Scand 2010 Dec. Epub 2010 des 10

Kroksveen A C, Opsahl J A, Aye T T, Ulvik R J, Berven F S. Proteomics of human cerebrospinal fluid: Discovery and verification of biomarker candidates in neurodegenerative diseases using quantitative proteomics. J Proteomics 2010 Nov. Epub 2010 nov 25

Kirkeleit Jorunn, Riise Trond, Bjørge Tone, Moen Bente E, Bråtveit Magne, Christiani David C. Increased risk of oesophageal adenocarcinoma among upstream petroleum workers. Occup Environ Med 2010 May;67(5):335-40. Epub 2009 okt 26

Zhang Liangxiao, Dai Hui, Liang Yizeng, Kvalheim Olav M. Detection and use of selective ions for providing initial estimates of the concentration vectors in iterative target transformation factor analysis. J Chromatogr A 2010 Apr;1217(18):3128-35. Epub 2010 feb 24

Zhang Liangxiao, Mjøs Svein A, Meier Sonnich, Kvalheim Olav M, Liang Yizeng The vector of calibration ratios: a simple transfer method for mass spectra. J Chromatogr A 2010 Sep;1217(38):5986-94. Epub 2010 jul 22

Teunissen C E, Tumani H T, Bennett J L, Berven F S, Brundin L, Comabella M, Franciotta D, Federiksen J L, Fleming J O, Furlan R, Hintzen R Q, Hughes S G, Johnson M H, Krasulova E, Kuhle J, Magnone Maria-Chiara, Petzold A, Rajda C, Rejdak K, Schmidt H K, van Pesch V, Waubant E, Wolf C, Hemmer B, Deisenhammer F, Giovannoni G Short commentary on 'a consensus protocol for the standardization of cerebrospinal fluid collection and biobanking'. Mult Scler 2010 Feb;16(2):129-32. Epub 2009 des 30

Berven Frode S, Ahmad Rushdy, Clauser Karl R, Carr Steven A Optimizing performance of glycopeptide capture for plasma proteomics. J Proteome Res 2010 Apr;9(4):1706-15.

Berle Magnus, Wester Knut G, Ulvik Rune J, Kroksveen Ann C, Haaland Oystein A, Amiry-Moghaddam Mahmood, Berven Frode S, Helland Christian A. Arachnoid cysts do not contain cerebrospinal fluid: A comparative chemical analysis of arachnoid cyst fluid and cerebrospinal fluid in adults. Cerebrospinal Fluid Res 2010;7():8. Epub 2010 jun 10

Arntzen Magnus Ø, Koehler Christian J, Barsnes Harald, Berven Frode S, Treumann Achim, Thiede Bernd IsobariQ: Software for Isobaric Quantitative Proteomics using IPTL, iTRAQ, and TMT. J Proteome Res 2010 Nov. Epub 2010 nov 29

Sanna Serena, Pitzalis Maristella, Zoledziewska Magdalena, Zara Ilenia, Sidore Carlo, Murru Raffaele, Whalen Michael B, Busonero Fabio, Maschio Andrea, Costa Gianna, Melis Maria Cristina, Deidda Francesca, Poddie Fausto, Morelli Laura, Farina Gabriele, Li Yun, Dei Mariano, Lai Sandra, Mulas Antonella, Cuccuru Gianmauro, Porcu Eleonora, Liang Liming, Zavattari Patrizia, Moi Loredana, Deriu Elisa, Urru M Francesca, Bajorek Michele, Satta Maria Anna, Cocco Eleonora, Ferrigno Paola, Sotgiu Stefano, Pugliatti Maura, Traccis Sebastiano, Angius Andrea, Melis Maurizio, Rosati Giulio, Abecasis Gonçalo R, Uda Manuela, Marrosu Maria Giovanna, Schlessinger David, Cucca Francesco. Variants within the immunoregulatory CBLB gene are associated with multiple sclerosis. Nat Genet 2010 Jun;42(6):495-7. Epub 2010 mai 9

Tallantyre Emma C, Bø Lars, Al-Rawashdeh Omar, Owens Trudy, Polman Chris H, Lowe James S, Evangelou Nikos. Clinico-pathological evidence that axonal loss underlies disability in progressive multiple sclerosis. Mult Scler 2010 Apr;16(4):406-11. Epub 2010 mar 9

Storstein Anette, Monstad Sissel Evy, Haugen Mette, Mazengia Kibret, Veltman Dana, Lohndal Emilia, Aarseth Jan, Vedeler Christian. Onconeural antibodies: Improved detection and clinical correlations. J Neuroimmunol 2010 Nov. Epub 2010 nov 18

Mero I-L, Ban M, Lorentzen A R, Smestad C, Celius E G, Sæther H, Saeedi H, Viken M K, Skinningsrud B, Undlien D E, Aarseth J, Myhr K-M, Granum S, Spurkland A, Sawcer S, Compston A, Lie B A, Harbo H F. Exploring the CLEC16A gene reveals a MS-associated variant with correlation to the relative expression of CLEC16A isoforms in thymus. Genes Immun 2010 Dec. Epub 2010 des 23

Ramagopalan Sreeram V, Hanwell Heather E C, Giovannoni Gavin, Knappskog Per Morten, Nyland Harald I, Myhr Kjell-Morten, Ebers George C, Torkildsen Oivind. Vitamin D-dependent rickets, HLA-DRB1, and the risk of multiple sclerosis. Arch Neurol 2010 Aug;67(8):1034-5.

Lorentzen Aslaug R, Melum Espen, Ellinghaus Eva, Smestad Cathrine, Mero Inger-Lise, Aarseth Jan H, Myhr Kjell-Morten, Celius Elisabeth G, Lie Benedicte A, Karlsen Tom H, Franke Andre, Harbo Hanne F. Association to the Glypican-5 gene in multiple sclerosis. J Neuroimmunol 2010 Sep;226(1-2):194-7. Epub 2010 aug 6

Smedal T, Myhr K-M, Aarseth J H, Gjelsvik B, Beiske A G, Glad S B, Strand L I. The influence of warm versus cold climate on the effect of physiotherapy in multiple sclerosis. Acta Neurol Scand 2010 Jul. Epub 2010 jul 15

Glad S B, Aarseth J H, Nyland H, Riise T, Myhr K-M. Benign multiple sclerosis: a need for a consensus. Acta Neurol Scand Suppl 2010.

Rajalahti Tarja, Kroksveen Ann C, Arneberg Reidar, Berven Frode S, Vedeler Christian A, Myhr Kjell-Morten, Kvalheim Olav M. A multivariate approach to reveal biomarker signatures for disease classification: application to mass spectral profiles of cerebrospinal fluid from patients with multiple sclerosis. J Proteome Res 2010 Jul;9(7):3608-20.

Naess Halvor, Glad Solveig, Storstein Anette, Rinaldo Christine H, Mørk Sverre J, Myhr Kjell-Morten, Hirsch Hans. Progressive multifocal leucoencephalopathy in an immunocompetent patient with favourable outcome. A case report. BMC Neurol 2010;10():32. Epub 2010 mai 18

Naess Halvor, Sundal Endre, Myhr Kjell-Morten, Nyland Harald Inge. Postinfectious and chronic fatigue syndromes: clinical experience from a tertiary-referral centre in Norway. In Vivo 2010 Mar-Apr;24(2):185-8.

Myhr Kjell-Morten. [Pharmacological treatment of multiple sclerosis]. Tidsskr Nor Laegeforen 2010 Mar;130(5):490-2.

Harbo H F, Riccio M E, Lorentzen A R, Utsi E, Myhr K-M, Mellgren S I, Flåm S T, Thorsby E, Sanchez-Mazas A, Lie B A. Norwegian Sami differs significantly from other Norwegians according to their HLA profile. Tissue Antigens 2010 Mar;75(3):207-17. Epub 2009 des 30

Lode K, Bru E, Klevan G, Myhr K M, Nyland H, Larsen J P. Coping with multiple sclerosis: a 5-year follow-up study. Acta Neurol Scand 2010 Nov;122(5):336-42.

Smedal T, Johansen H H, Myhr K-M, Strand L. Psychometric properties of a Norwegian version of Multiple Sclerosis Impact Scale (MSIS-29). Acta Neurol Scand 2010 Oct;122(4):244-51. Epub 2009 nov 23

Torkildsen Øivind, Stansberg Christine, Angelskår Solveig M, Kooi Evert-Jan, Geurts Jeroen J G, Van der Valk Paul, Myhr Kjell- Morten, Steen Vidar M, Bø Lars. Upregulation of immunoglobulin-related genes in cortical sections from multiple sclerosis patients. Brain Pathol 2010 Jul;20(4):720-9. Epub 2009 okt 16

Mero Inger-Lise, Lorentzen Aslaug R, Ban Maria, Smestad Cathrine, Celius Elisabeth G, Aarseth Jan H, Myhr Kjell-Morten, Link Jenny, Hillert Jan, Olsson Tomas, Kockum Ingrid, Masterman Thomas, Oturai Annette Bang, Søndergaard Helle Bach, Sellebjerg Finn, Saarela Janna, Kemppinen Anu, Elovaara Irina, Spurkland Anne, Dudbridge Frank, Lie Benedicte A, Harbo Hanne F. A rare variant of the TYK2 gene is confirmed to be associated with multiple sclerosis. Eur J Hum Genet 2010 Apr;18(4):502-4. Epub 2009 nov 4